<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6479889</article-id><article-id pub-id-type="doi">10.3390/ijms20071667</article-id><article-id pub-id-type="publisher-id">ijms-20-01667</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Fritillariae Thunbergii Bulbus: Traditional Uses, Phytochemistry, Pharmacodynamics, Pharmacokinetics and Toxicity</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3874-4860</contrib-id><name><surname>Li</surname><given-names>Hong</given-names></name><xref ref-type="aff" rid="af1-ijms-20-01667">1</xref></contrib><contrib contrib-type="author"><name><surname>Hung</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="af2-ijms-20-01667">2</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Mingdi</given-names></name><xref ref-type="aff" rid="af1-ijms-20-01667">1</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Angela Wei Hong</given-names></name><xref ref-type="aff" rid="af1-ijms-20-01667">1</xref><xref rid="c1-ijms-20-01667" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-ijms-20-01667"><label>1</label>School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria 3083, Australia; <email>s3640112@student.rmit.edu.au</email> (H.L.); <email>s3335658@student.rmit.edu.au</email> (M.L.)</aff><aff id="af2-ijms-20-01667"><label>2</label>School of Science, RMIT University, Melbourne, Victoria 3001, Australia; <email>andrew.hung@rmit.edu.au</email></aff><author-notes><corresp id="c1-ijms-20-01667"><label>*</label>Correspondence: <email>angela.yang@rmit.edu.au</email>; Tel.: +61-3-9925-7175; Fax: +61-3-9925-7178</corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>4</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2019</year></pub-date><volume>20</volume><issue>7</issue><elocation-id>1667</elocation-id><history><date date-type="received"><day>15</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>30</day><month>3</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Fritillariae Thunbergii Bulbus (FTB) has been widely used as an antitussive herb for thousands of years in China. However, FTB&#x02019;s traditional uses, chemical compounds and pharmacological activities have not been systematically reviewed. This study aimed to review its traditional uses, phytochemistry, pharmacodynamics, pharmacokinetics and toxicity. We searched the Encyclopedia of Traditional Chinese Medicine to explore the historical records which indicate that it acts to clear heat, resolve phlegm, relieve cough, remove toxicity and disperse abscesses and nodules. We searched 11 databases to identify potential phytochemical or pharmacological studies. Characteristics of its chemical constituents, pharmacological effects, pharmacokinetic and toxicity were descriptively summarized. A total of 9706 studies were identified and 83 of them were included. As a result, 134 chemical constituents were identified, including 26 alkaloids, 29 compounds found in essential oils, 13 diterpenoids, two carbohydrates, two sterols, 18 amino acids, six nucleosides, four nucleobases, four fatty acids, three lignans, and 27 elements. Thirteen pharmacological effects of FTB were identified, including anti-cancer, tracheobronchial relaxation, antitussive, expectorant, anti-muscarinic, anti-inflammation, anti-thyroid, regulation of blood rheology, antiulcer, anti-diarrhea, pain suppression, antioxidation and neuroprotection. These pharmacological activities may be mainly attributed to the alkaloids in FTB. Further phytochemical, pharmacological and network pharmacological studies are recommended.</p></abstract><kwd-group><kwd>natural product</kwd><kwd>traditional medicine</kwd><kwd>complementary and alternative medicine</kwd><kwd>herbal medicine</kwd><kwd>review</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-ijms-20-01667"><title>1. Introduction</title><p>Fritillariae Thunbergii Bulbus (FTB) is also known as Zhe bei mu or Xiang bei mu in Chinese, Setsubaimo in Japanese and Jeolpaemo in Korean [<xref rid="B1-ijms-20-01667" ref-type="bibr">1</xref>]. Fritillariae Thunbergii belongs to the Fritillariae (Liliaceae) family and FTB has been widely used as an antitussive herb for thousands of years in China [<xref rid="B2-ijms-20-01667" ref-type="bibr">2</xref>]. Fritillariae Thunbergii is widely cultivated in the south-eastern coastal, south-central and eastern areas of China, such as Zhejiang, Jiangsu, Anhui and Hunan provinces [<xref rid="B2-ijms-20-01667" ref-type="bibr">2</xref>]. FTB is a significant traditional Chinese herb with bitter and cold properties, entering the Lung and Heart channels [<xref rid="B2-ijms-20-01667" ref-type="bibr">2</xref>]. It is generally prescribed as one of the ingredients of herbal formula, such as Danggui Beimu Kushen Wan (Chinese Angelica, Fritillaria and Flavescent Sophora Pill; DBKW) in traditional and contemporary clinical practice [<xref rid="B3-ijms-20-01667" ref-type="bibr">3</xref>,<xref rid="B4-ijms-20-01667" ref-type="bibr">4</xref>]. Recently, investigating potential treatments from ancient records has been employed as a strategy to direct novel drug discovery [<xref rid="B5-ijms-20-01667" ref-type="bibr">5</xref>]. Modern studies that are recorded in the Zhong Yao Da Ci Dian (Great Compendium of Chinese Medicines) [<xref rid="B6-ijms-20-01667" ref-type="bibr">6</xref>] and Zhong Hua Ben Cao (Chinese Pharmacopoeia) [<xref rid="B7-ijms-20-01667" ref-type="bibr">7</xref>] indicated that the pharmacological effects of FTB include antitussive, tracheobronchial relaxation, anti-muscarinic, expectorant and pain suppression with a wide range of chemical constituents, such as peimine and peiminine. With the development of modern methodological approaches, an increasing number of new chemical constituents (e.g., frithunbol A and frithunbol B) [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>], and pharmacological effects (e.g., anti-cancer activity [<xref rid="B9-ijms-20-01667" ref-type="bibr">9</xref>] and neuroprotection [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]) have been found in FTB. Therefore, there is a need to thoroughly review FTB from traditional and modern perspectives to assist further drug discovery. This study aimed to review traditional uses, phytochemical, pharmacodynamic, pharmacokinetic and toxicity characteristics of FTB and provide comprehensive and evidence-based information to practitioners and researchers.</p></sec><sec id="sec2-ijms-20-01667"><title>2. Traditional Uses of FTB</title><p>The Zhong Hua Yi Dian (Encyclopedia of Traditional Chinese Medicine; ZHYD) CD-ROM, containing 1156 ancient books, was searched to identify potential classic literature of FTB [<xref rid="B10-ijms-20-01667" ref-type="bibr">10</xref>]. FTB was first documented in the book Ben Cao Hui Yan (BCHY, Discourse on Herbal Medicine, NI Zhumo, 1624, Ming Dynasty), with its actions described as breaking blood and detoxication. In addition, five classic books, including Ben Cao Zheng Yao (Evidence of Materia Medica, LI Zhongzi, 1673, Qing dynasty), Ben Jing Feng Yuan (Doctrine of Origin, ZHANG Lu, 1695, Qing dynasty), Ben Cao Gang Mu Shi Yi (Supplement to the Compendium of Materia Medica, ZHAO Xuemin, 1765, Qing dynasty), Ben Cao Bian Du (Simple Materia Medica, ZHANG Bingcheng, 1887, Qing dynasty) and Ben Cao Zheng Yi (Merits of Herbal Medicine, ZHANG Shanlei, 1920, Republic of China), specified that the unique actions of FTB were to clear the Lung and calm the Liver, disperse the Lung-Qi to relieve depression, clear the Heart and reduce the heat, which were not found in other Fritillariae species, such as Fritillariae Cirrhosae Bulbus (Chuan bei mu) and Bulbus Bolbostemmatis Rhizoma (Tu Bei Mu). In summary, FTB acts to clear heat, resolve phlegm, relieve cough, remove toxicity and disperse abscesses and nodules. A number of herbal formulas containing FTB were identified. <xref ref-type="app" rid="app1-ijms-20-01667">Supplementary file 1</xref> presents some example formulas containing FTB as an ingredient in ZHYD. Herbal ingredients in <xref ref-type="app" rid="app1-ijms-20-01667">Supplementary file 1</xref> are listed as Chinese pinyin name as per the nomenclature list of commonly used Chinese herbal medicines published by the Chinese Medicine Board of Australia [<xref rid="B11-ijms-20-01667" ref-type="bibr">11</xref>]. Today, some of them are continuously used by practitioners in evidence-based Chinese medicine clinical practice, such as DBKW, Guang Bi Shu Zhan Tang (Throat Tuberculosis Decoction), Xiao Lei Wan (Eliminate Scrofula Pill), Xing Su Yin (Apricot Kernel and Perilla Leaf Decoction), Qing Jin Ning Sou Tang (Clear the Lung and Stop Cough Decoction), Tuo Li Pai Nong Tang (Support the Interior and Drain Pus Decoction), Ren Shen Bai Du San (Ginseng Powder to Overcome Toxin) and Xian Fang Huo Ming Yin (Sublime Formula for Sustaining Life).</p><p>In terms of the indications of FTB, Ben Cao Zheng (Orthodox Materia Medica, ZHANG Jiebin, 1624, Ming dynasty) recorded that it could be used for a number of conditions, including lung abscess, lung atrophy, cough, dyspnea, hematemesis, epistaxis, hematochezia, hematuria, jaundice, difficult urination, pharyngitis, hemorrhoid, anal fistula, acute mastitis, scrofula and any furuncles, carbuncle, abscess and other inflammation and swelling. Ben Cao Cong Xin (New Revised Materia Medica, WU Yiluo, 1751, Qing dynasty) claimed that FTB could be utilized for patients with flu induced by wind-phlegm. Ben Cao Gang Mu Shi Yi provided further descriptions that the indications of FTB could be extended to any respiratory disorders which are due to wind-fire and phlegm. As shown in <xref ref-type="app" rid="app1-ijms-20-01667">Supplementary file 1</xref>, those formulas had been widely used in various disciplines along with the development of Chinese medicine, including otorhinolaryngology, ophthalmology, external medicine, gynecology, obstetrics, galactophore and infectious diseases.</p></sec><sec id="sec3-ijms-20-01667"><title>3. Modern Exploration of FTB</title><p>The following seven English and four Chinese electronic databases were searched from their respective inceptions to 2 November 2018: PubMed, EMBASE, CINAHL, Science Direct, Scopus, ProQuest, Allied and Complementary Medicine Database, CNKI, CQVIP, Wanfangdata and CBM. Keywords used to identify potential studies included: Zhe bei mu and its English, Latin, Japanese, Korean, botanical and pharmaceutical names and their synonyms. The reference list of review articles was screened manually for potential studies.</p><p>Original experimental studies on phytochemistry and pharmacology, or the studies containing phytochemical or pharmacological tests, published in English or Chinese, were considered for inclusion, regardless of the type of experimental studies (e.g., in vivo and in vitro). The studies were included if they investigated a single raw herb with species and specific medicinal parts of FTB listed in the Pharmacopoeia of the People&#x02019;s Republic of China. The literature was excluded if they are review articles or do not include original phytochemical or pharmacological studies, or did not use a raw herb with appropriate species or medicinal parts of FTB, or directly used chemical compounds instead of a raw herb as the research material, or published in a non-English or non-Chinese language.</p><p>One reviewer (HL) screened the searched literature and extracted the following data to a predesigned Excel form: Compound name, molecular formula, molecular weight, molecular structure and analysis methods for phytochemical studies; and compound name, study type, characteristics of sample, interventions, duration, outcome measures, main results for pharmacological studies. Corresponding molecular structures were further searched in the PubChem database to obtain the PubChem CID/SID number. The molecular structures that could not be found in PubChem were drawn manually using the software ChemDraw. All included studies were divided into two groups: Studies reporting a voucher number (SRV) and studies not reporting voucher number (SNRV). A voucher specimen number is one of the most significant requirements for phytological studies, since it ensures the reliability of botanical taxon and the repeatability of published studies [<xref rid="B12-ijms-20-01667" ref-type="bibr">12</xref>,<xref rid="B13-ijms-20-01667" ref-type="bibr">13</xref>]. The data was checked and confirmed by the second reviewer (ML). When any discrepancies between the two reviewers occurred, they were discussed with the third party (AY) to resolve the issues. A descriptive summary was performed to obtain the characteristics of the extracted data.</p><p>A total of 9706 experimental studies were identified adhering to the search strategies mentioned above. Eighty-three studies meeting the inclusion criteria were included for analysis, including 63 phytochemical studies [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>,<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>,<xref rid="B15-ijms-20-01667" ref-type="bibr">15</xref>,<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>,<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>,<xref rid="B18-ijms-20-01667" ref-type="bibr">18</xref>,<xref rid="B19-ijms-20-01667" ref-type="bibr">19</xref>,<xref rid="B20-ijms-20-01667" ref-type="bibr">20</xref>,<xref rid="B21-ijms-20-01667" ref-type="bibr">21</xref>,<xref rid="B22-ijms-20-01667" ref-type="bibr">22</xref>,<xref rid="B23-ijms-20-01667" ref-type="bibr">23</xref>,<xref rid="B24-ijms-20-01667" ref-type="bibr">24</xref>,<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>,<xref rid="B26-ijms-20-01667" ref-type="bibr">26</xref>,<xref rid="B27-ijms-20-01667" ref-type="bibr">27</xref>,<xref rid="B28-ijms-20-01667" ref-type="bibr">28</xref>,<xref rid="B29-ijms-20-01667" ref-type="bibr">29</xref>,<xref rid="B30-ijms-20-01667" ref-type="bibr">30</xref>,<xref rid="B31-ijms-20-01667" ref-type="bibr">31</xref>,<xref rid="B32-ijms-20-01667" ref-type="bibr">32</xref>,<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>,<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>,<xref rid="B35-ijms-20-01667" ref-type="bibr">35</xref>,<xref rid="B36-ijms-20-01667" ref-type="bibr">36</xref>,<xref rid="B37-ijms-20-01667" ref-type="bibr">37</xref>,<xref rid="B38-ijms-20-01667" ref-type="bibr">38</xref>,<xref rid="B39-ijms-20-01667" ref-type="bibr">39</xref>,<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>,<xref rid="B41-ijms-20-01667" ref-type="bibr">41</xref>,<xref rid="B42-ijms-20-01667" ref-type="bibr">42</xref>,<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>,<xref rid="B44-ijms-20-01667" ref-type="bibr">44</xref>,<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>,<xref rid="B46-ijms-20-01667" ref-type="bibr">46</xref>,<xref rid="B47-ijms-20-01667" ref-type="bibr">47</xref>,<xref rid="B48-ijms-20-01667" ref-type="bibr">48</xref>,<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>,<xref rid="B50-ijms-20-01667" ref-type="bibr">50</xref>,<xref rid="B51-ijms-20-01667" ref-type="bibr">51</xref>,<xref rid="B52-ijms-20-01667" ref-type="bibr">52</xref>,<xref rid="B53-ijms-20-01667" ref-type="bibr">53</xref>,<xref rid="B54-ijms-20-01667" ref-type="bibr">54</xref>,<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>,<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>,<xref rid="B57-ijms-20-01667" ref-type="bibr">57</xref>,<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>,<xref rid="B59-ijms-20-01667" ref-type="bibr">59</xref>,<xref rid="B60-ijms-20-01667" ref-type="bibr">60</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>,<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>,<xref rid="B63-ijms-20-01667" ref-type="bibr">63</xref>,<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>,<xref rid="B65-ijms-20-01667" ref-type="bibr">65</xref>,<xref rid="B66-ijms-20-01667" ref-type="bibr">66</xref>,<xref rid="B67-ijms-20-01667" ref-type="bibr">67</xref>,<xref rid="B68-ijms-20-01667" ref-type="bibr">68</xref>,<xref rid="B69-ijms-20-01667" ref-type="bibr">69</xref>,<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>,<xref rid="B71-ijms-20-01667" ref-type="bibr">71</xref>,<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>,<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>,<xref rid="B74-ijms-20-01667" ref-type="bibr">74</xref>,<xref rid="B75-ijms-20-01667" ref-type="bibr">75</xref>] and 30 pharmacological studies [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>,<xref rid="B9-ijms-20-01667" ref-type="bibr">9</xref>,<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>,<xref rid="B27-ijms-20-01667" ref-type="bibr">27</xref>,<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>,<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>,<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>,<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>,<xref rid="B59-ijms-20-01667" ref-type="bibr">59</xref>,<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>,<xref rid="B75-ijms-20-01667" ref-type="bibr">75</xref>,<xref rid="B76-ijms-20-01667" ref-type="bibr">76</xref>,<xref rid="B77-ijms-20-01667" ref-type="bibr">77</xref>,<xref rid="B78-ijms-20-01667" ref-type="bibr">78</xref>,<xref rid="B79-ijms-20-01667" ref-type="bibr">79</xref>,<xref rid="B80-ijms-20-01667" ref-type="bibr">80</xref>,<xref rid="B81-ijms-20-01667" ref-type="bibr">81</xref>,<xref rid="B82-ijms-20-01667" ref-type="bibr">82</xref>,<xref rid="B83-ijms-20-01667" ref-type="bibr">83</xref>,<xref rid="B84-ijms-20-01667" ref-type="bibr">84</xref>,<xref rid="B85-ijms-20-01667" ref-type="bibr">85</xref>,<xref rid="B86-ijms-20-01667" ref-type="bibr">86</xref>,<xref rid="B87-ijms-20-01667" ref-type="bibr">87</xref>,<xref rid="B88-ijms-20-01667" ref-type="bibr">88</xref>,<xref rid="B89-ijms-20-01667" ref-type="bibr">89</xref>,<xref rid="B90-ijms-20-01667" ref-type="bibr">90</xref>,<xref rid="B91-ijms-20-01667" ref-type="bibr">91</xref>,<xref rid="B92-ijms-20-01667" ref-type="bibr">92</xref>,<xref rid="B93-ijms-20-01667" ref-type="bibr">93</xref>,<xref rid="B94-ijms-20-01667" ref-type="bibr">94</xref>], as 10 studies reported both phytochemical and pharmacological effects of FTB [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>,<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>,<xref rid="B27-ijms-20-01667" ref-type="bibr">27</xref>,<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>,<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>,<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>,<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>,<xref rid="B59-ijms-20-01667" ref-type="bibr">59</xref>,<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>,<xref rid="B75-ijms-20-01667" ref-type="bibr">75</xref>]. <xref ref-type="fig" rid="ijms-20-01667-f001">Figure 1</xref> details the selection process of included studies.</p><sec id="sec3dot1-ijms-20-01667"><title>3.1. Phytochemistry of FTB</title><p>A total of 134 chemical constituents were identified, including 26 alkaloids (A1&#x02013;A26), 29 compounds found in essential oils (B1&#x02013;B29), 13 diterpenoids (C1&#x02013;C13), two carbohydrates (D1&#x02013;D2), two sterols (E1&#x02013;E2), 18 amino acids (F1&#x02013;F18), six nucleosides (G1&#x02013;G6), four nucleobases (H1&#x02013;H4), four fatty acids (I1&#x02013;I4), three lignans (J1&#x02013;J3), and 27 elements (K1&#x02013;K27). <xref rid="ijms-20-01667-t001" ref-type="table">Table 1</xref> details the characteristics of chemical constituents isolated from FTB. </p><p>Within 63 included phytochemical studies, there are 17 SRV (47 constituents isolated) [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>,<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>,<xref rid="B21-ijms-20-01667" ref-type="bibr">21</xref>,<xref rid="B26-ijms-20-01667" ref-type="bibr">26</xref>,<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>,<xref rid="B38-ijms-20-01667" ref-type="bibr">38</xref>,<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>,<xref rid="B44-ijms-20-01667" ref-type="bibr">44</xref>,<xref rid="B50-ijms-20-01667" ref-type="bibr">50</xref>,<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>,<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>,<xref rid="B60-ijms-20-01667" ref-type="bibr">60</xref>,<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>,<xref rid="B63-ijms-20-01667" ref-type="bibr">63</xref>,<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>,<xref rid="B71-ijms-20-01667" ref-type="bibr">71</xref>,<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>] and 46 SNRV (118 constituents isolated) [<xref rid="B15-ijms-20-01667" ref-type="bibr">15</xref>,<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>,<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>,<xref rid="B18-ijms-20-01667" ref-type="bibr">18</xref>,<xref rid="B19-ijms-20-01667" ref-type="bibr">19</xref>,<xref rid="B20-ijms-20-01667" ref-type="bibr">20</xref>,<xref rid="B22-ijms-20-01667" ref-type="bibr">22</xref>,<xref rid="B23-ijms-20-01667" ref-type="bibr">23</xref>,<xref rid="B24-ijms-20-01667" ref-type="bibr">24</xref>,<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>,<xref rid="B26-ijms-20-01667" ref-type="bibr">26</xref>,<xref rid="B27-ijms-20-01667" ref-type="bibr">27</xref>,<xref rid="B28-ijms-20-01667" ref-type="bibr">28</xref>,<xref rid="B29-ijms-20-01667" ref-type="bibr">29</xref>,<xref rid="B30-ijms-20-01667" ref-type="bibr">30</xref>,<xref rid="B31-ijms-20-01667" ref-type="bibr">31</xref>,<xref rid="B32-ijms-20-01667" ref-type="bibr">32</xref>,<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>,<xref rid="B35-ijms-20-01667" ref-type="bibr">35</xref>,<xref rid="B36-ijms-20-01667" ref-type="bibr">36</xref>,<xref rid="B37-ijms-20-01667" ref-type="bibr">37</xref>,<xref rid="B39-ijms-20-01667" ref-type="bibr">39</xref>,<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>,<xref rid="B41-ijms-20-01667" ref-type="bibr">41</xref>,<xref rid="B42-ijms-20-01667" ref-type="bibr">42</xref>,<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>,<xref rid="B46-ijms-20-01667" ref-type="bibr">46</xref>,<xref rid="B47-ijms-20-01667" ref-type="bibr">47</xref>,<xref rid="B48-ijms-20-01667" ref-type="bibr">48</xref>,<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>,<xref rid="B51-ijms-20-01667" ref-type="bibr">51</xref>,<xref rid="B52-ijms-20-01667" ref-type="bibr">52</xref>,<xref rid="B53-ijms-20-01667" ref-type="bibr">53</xref>,<xref rid="B54-ijms-20-01667" ref-type="bibr">54</xref>,<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>,<xref rid="B57-ijms-20-01667" ref-type="bibr">57</xref>,<xref rid="B59-ijms-20-01667" ref-type="bibr">59</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>,<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>,<xref rid="B65-ijms-20-01667" ref-type="bibr">65</xref>,<xref rid="B66-ijms-20-01667" ref-type="bibr">66</xref>,<xref rid="B69-ijms-20-01667" ref-type="bibr">69</xref>,<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>,<xref rid="B74-ijms-20-01667" ref-type="bibr">74</xref>,<xref rid="B75-ijms-20-01667" ref-type="bibr">75</xref>]. Thirty-one chemical constituents were identified in both SRV and SNRV groups, including nine alkaloids (A1, A2, A5, A6, A7, A9, A11, A14 and A15), four nucleosides (G1-G4), one nucleobases (I1), and 17 elements (K1, K2, K6-K12, K14, K16, K17, K19, K20, K22, K25 and K27). In terms of the molecular structures, 117 chemical constituents were found in the PubChem database that refers to the corresponding PubChem CID/SID, however, 17 constituents were not available in PubChem. Amount of the 17 chemical components, 14 of the molecular structures (A4, A11, A16, A17, A27, A30-A33, C2-C4, C9 and C12) could be found in the included studies and three of them (A10, A22 and D1) could not be found anywhere. Details of the 14 molecular structures were presented in <xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>.</p><sec id="sec3dot1dot1-ijms-20-01667"><title>3.1.1. Alkaloids</title><p>Current studies mainly focused on the alkaloids which are the fundamental components of FTB [<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>]. Among 26 isolated alkaloids in FTB, 0.080% of peimine (A1) and peiminine (A2) used for identification and quality control as listed in the Pharmacopeia of People&#x02019;s Republic of China [<xref rid="B2-ijms-20-01667" ref-type="bibr">2</xref>]. These two compounds were first isolated in 1960 using the paper partition chromatography method [<xref rid="B46-ijms-20-01667" ref-type="bibr">46</xref>] and then they were consistently found by over 40 research teams using more than 20 different methods from 1960 to 2018 [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>,<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>,<xref rid="B18-ijms-20-01667" ref-type="bibr">18</xref>,<xref rid="B20-ijms-20-01667" ref-type="bibr">20</xref>,<xref rid="B21-ijms-20-01667" ref-type="bibr">21</xref>,<xref rid="B22-ijms-20-01667" ref-type="bibr">22</xref>,<xref rid="B23-ijms-20-01667" ref-type="bibr">23</xref>,<xref rid="B24-ijms-20-01667" ref-type="bibr">24</xref>,<xref rid="B26-ijms-20-01667" ref-type="bibr">26</xref>,<xref rid="B27-ijms-20-01667" ref-type="bibr">27</xref>,<xref rid="B28-ijms-20-01667" ref-type="bibr">28</xref>,<xref rid="B29-ijms-20-01667" ref-type="bibr">29</xref>,<xref rid="B31-ijms-20-01667" ref-type="bibr">31</xref>,<xref rid="B32-ijms-20-01667" ref-type="bibr">32</xref>,<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>,<xref rid="B36-ijms-20-01667" ref-type="bibr">36</xref>,<xref rid="B37-ijms-20-01667" ref-type="bibr">37</xref>,<xref rid="B38-ijms-20-01667" ref-type="bibr">38</xref>,<xref rid="B39-ijms-20-01667" ref-type="bibr">39</xref>,<xref rid="B41-ijms-20-01667" ref-type="bibr">41</xref>,<xref rid="B42-ijms-20-01667" ref-type="bibr">42</xref>,<xref rid="B44-ijms-20-01667" ref-type="bibr">44</xref>,<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>,<xref rid="B47-ijms-20-01667" ref-type="bibr">47</xref>,<xref rid="B48-ijms-20-01667" ref-type="bibr">48</xref>,<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>,<xref rid="B51-ijms-20-01667" ref-type="bibr">51</xref>,<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>,<xref rid="B57-ijms-20-01667" ref-type="bibr">57</xref>,<xref rid="B59-ijms-20-01667" ref-type="bibr">59</xref>,<xref rid="B60-ijms-20-01667" ref-type="bibr">60</xref>,<xref rid="B63-ijms-20-01667" ref-type="bibr">63</xref>,<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>,<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>,<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>,<xref rid="B75-ijms-20-01667" ref-type="bibr">75</xref>]. The in vivo and in vitro experimental studies identified the biological activities of peimine (A1) and peiminine (A2), such as anti-cancer activity [<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>], tracheobronchial relaxation [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>], anti-muscarinic activity [<xref rid="B75-ijms-20-01667" ref-type="bibr">75</xref>], anti-inflammatory activity [<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>,<xref rid="B88-ijms-20-01667" ref-type="bibr">88</xref>], and pain suppression [<xref rid="B88-ijms-20-01667" ref-type="bibr">88</xref>], which indicates they may have great potential in clinical practice. In addition, some isomers were also reported, including peimine (A1) [<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>], zhebeinine (A3) [<xref rid="B68-ijms-20-01667" ref-type="bibr">68</xref>] and isoverticine (A7) [<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>] with the same molecular formula C<sub>27</sub>H<sub>45</sub>NO<sub>3</sub>, peiminine (A2) [<xref rid="B21-ijms-20-01667" ref-type="bibr">21</xref>], zhebeinone (A4) [<xref rid="B65-ijms-20-01667" ref-type="bibr">65</xref>] and suchengbeisine (A8) [<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>] with the same molecular formula C<sub>27</sub>H<sub>43</sub>NO<sub>3</sub>, ebeiedine (A5) [<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>], puqiedine (A15) [<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>], N-demethylpuqietinon (A19) [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>] and eduardinine (A25) [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>] with the same molecular formula C<sub>27</sub>H<sub>45</sub>NO<sub>2</sub>, ebeiedinone (A6) [<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>], puqiedinone (A14) [<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>], eduardine (A16) [<xref rid="B66-ijms-20-01667" ref-type="bibr">66</xref>] and zhebeirine (A17) [<xref rid="B66-ijms-20-01667" ref-type="bibr">66</xref>] with the same molecular formula C<sub>27</sub>H<sub>43</sub>NO<sub>2</sub>, and frithunbol B (A24) [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>] and 3&#x003b2;-hydroxy-5&#x003b1;-jervanin-12-en-6-one (A26) [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>] with the same molecular formula C<sub>27</sub>H<sub>42</sub>NO<sub>3</sub>. Another two new steroidal alkaloids were isolated and identified in 2018 [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]. They are the colorless gum called frithunbol A (A23) and frithunbol B (A24) with the structures 5&#x003b1;-cevanin-13-ene-3&#x003b2;,6&#x003b1;,16&#x003b2;-triol-18-one and 3&#x003b2;-hydroxy-5&#x003b1;-jerv-12-en-6-one respectively, presented in <xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>. Frithunbol B (A24) could reduce nitric oxide (NO) in vitro and it may possess neuroprotective activity [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>].</p></sec><sec id="sec3dot1dot2-ijms-20-01667"><title>3.1.2. Compounds from Essential Oils</title><p>A total of 29 compounds found in essential oils in FTB were investigated in two recent experimental studies using the gas chromatography&#x02013;mass spectrometry method. One study reported 15 of them, including &#x003b4;-elemene (B1), &#x003b4;-selinene (B2), tetradecanoic acid (B3), pentadecanoic acid (B4), hexadecanoic acid, methyl ester (B5), 9-hexadecenoic acid (B6), n-hexadecanoic acid (B7), kaur-15-ene (B8), heptadecanoic acid (B9), kaurene (B10), 9,12-octadecadienoic acid (Z,Z)-, methyl ester (B11), 9-tetradecenal, (Z)- (B12), 9,12-octadecadienoic acid, methyl ester, (E, E)- (B13), oleic acid (B14), and linoleic acid, ethyl ester (B15) [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]. Among these 15 constituents, n-hexadecanoic acid (B7), 9,12-octadecadienoic acid, methyl ester, (E, E)- (B13), and oleic acid (B14) were the three primary compounds found in essential oils in FTB accounting for 53.46%, 26.96% and 9.34% respectively. Another study also found hexadecanoic acid, methyl ester (B5), and reported another 14 chemical compounds, including butylated hydroxytoluene (B16), L-(+)-Ascorbic acid 2,6-dihexadecanoate (B17), ethyl 9-hexadecenoate (B18), hexadecanoic acid, ethyl ester (B19), 1H-naphtho [2,1-B] pyran, 3-ethenyldodecahydro-3,4a,7,7,10a-pentamethyl- (B20), kaur-16-ene (B21), 9,11-octadecadienoic acid, methyl ester, (E, E)- (B22), 9,12-octadecadienoic acid (B23), linoleic acid, ethyl ester (B24), octadecanoic acid, ethyl ester (B25), 2(1H)-phenanthrenone, 3,4,4a,4b,5,6,7,8,10,10a-decahydro-1,1,4a,7,7-pentamethyl, [4aR-(4a.&#x003b1;., 4b.&#x003b2;.,10a.&#x003b2;.)]- (B26), 3-methyleneandrostan-17-ol (B27), androst-4-En-3-one, 17-hydroxy-, (17.&#x003b2;.) (B28), and podocarp-7-en-3.&#x003b2;.-ol, 13.&#x003b2;.-methyl-13-vinyl- (B29) [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]. The latter study stated the proportion of four main compounds found in essential oils: Linoleic acid, ethyl ester (B24; 36.93%), kaur-16-ene (B21; 22.85%), hexadecanoic acid, methyl ester (B5; 10.67%), and 3-methyleneandrostan-17-ol (B27; 10.59%). However, the proportion of hexadecanoic acid, methyl ester (B5) in the former study was only 0.6% [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]. It is worth noting that different compounds from essential oils with different proportions from FTB have been identified, due to the different isolation methods. The former study soaked FTB powders for 12 h and distilled it for 10 h [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>] whereas the soak time and distillation time in the later study were one hour and five hours respectively [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]. Further studies should consider utilizing the appropriate isolation method to achieve selective isolation of target compounds. However, at the current stage, there is no solid evidence to identify which isolation method is better.</p></sec><sec id="sec3dot1dot3-ijms-20-01667"><title>3.1.3. Diterpenoids</title><p>Two studies conducted by the same Japanese research team in 1984 focused on the diterpenoids in FTB [<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>,<xref rid="B35-ijms-20-01667" ref-type="bibr">35</xref>]. Thirteen diterpenoids were identified using the nuclear magnetic resonance methods (1HNMR and 13CNMR), including isopimaran-19-ol (C1), isopimaran-19-oic acid, methyl ester (C2), ent-kauran-16&#x003b2;, 17-diol (C3), ent-kauran-16&#x003b1;, 17-diol (C4), ent-16&#x003b2;, 17-epoxy-kaurane (C5), ent-16&#x003b1;-methoxy-kauran-17-ol (C6), ent-kaur-15-en-17-ol (C7), trans-communol (C8), trans-comminic acid, methyl ester (C9), ent-17-norkauran-16-one (C10), ent-15&#x003b2;,16-epoxy-kauran-17-ol (C11), ent-16&#x003b2;-hydroxy-kauran-17-yl ent-kaur-15-en-17-oate (C12), and ent-(16S)-atisan-13, 17-oxide (C13) [<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>,<xref rid="B35-ijms-20-01667" ref-type="bibr">35</xref>]. However, no further studies, after 1984, were found on the investigation of the diterpenoids or the specific diterpenoids identified from FTB. As diterpenoids in other Chinese herbs may perform diverse biological activities, such as anti-cancer activity [<xref rid="B95-ijms-20-01667" ref-type="bibr">95</xref>], anti-inflammatory activity [<xref rid="B96-ijms-20-01667" ref-type="bibr">96</xref>] and antioxidative activity [<xref rid="B97-ijms-20-01667" ref-type="bibr">97</xref>], further studies which focus attention on diterpenoids in FTB may be important.</p></sec><sec id="sec3dot1dot4-ijms-20-01667"><title>3.1.4. Nucleosides</title><p>Three studies identified six nucleosides from FTB using three different methods (LC-ESI-MSn [<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>], HPLC-UV-ESI/MS [<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>] and HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>,<xref rid="B71-ijms-20-01667" ref-type="bibr">71</xref>]), including uridine (G1), guanosine (G2), adenosine (G3), thymidine (G4), cytidine (G5), and inosine (G6). One of the studies highlighted that the content of nucleosides in FTB could be used as an index for the identification and quality control of FTB [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]. However, to date, none of the included studies evaluated the pharmacological activities of nucleosides isolated from FTB. As the basic building-block of DNA and RNA, nucleosides from other plants possess many biological activities, such as anti-cancer activity [<xref rid="B98-ijms-20-01667" ref-type="bibr">98</xref>], antibacterial activity [<xref rid="B99-ijms-20-01667" ref-type="bibr">99</xref>], and antiviral activity [<xref rid="B100-ijms-20-01667" ref-type="bibr">100</xref>]. It is worth investigating nucleosides in FTB for novel drug discovery.</p></sec><sec id="sec3dot1dot5-ijms-20-01667"><title>3.1.5. Elements</title><p>A total of 27 elements were found for identification and quality control purposes [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>,<xref rid="B15-ijms-20-01667" ref-type="bibr">15</xref>,<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>,<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>,<xref rid="B52-ijms-20-01667" ref-type="bibr">52</xref>,<xref rid="B53-ijms-20-01667" ref-type="bibr">53</xref>,<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>,<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>,<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>,<xref rid="B74-ijms-20-01667" ref-type="bibr">74</xref>]. Eight of them are trace elements that may have vital biological activities in the human body, including cobalt, copper, iron, manganese, molybdenum, sulfur, selenium and zinc [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>,<xref rid="B15-ijms-20-01667" ref-type="bibr">15</xref>,<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>,<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>,<xref rid="B52-ijms-20-01667" ref-type="bibr">52</xref>,<xref rid="B54-ijms-20-01667" ref-type="bibr">54</xref>,<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>,<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>,<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>,<xref rid="B74-ijms-20-01667" ref-type="bibr">74</xref>]. Another six trace elements without any known biological activities were identified in FTB, including arsenic, cadmium, chromium, mercury, nickel and lead [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>,<xref rid="B15-ijms-20-01667" ref-type="bibr">15</xref>,<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>,<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>,<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>,<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>,<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>,<xref rid="B74-ijms-20-01667" ref-type="bibr">74</xref>]. They have toxic activities that may damage the lipids, proteins, enzymes and DNA even in low dose [<xref rid="B101-ijms-20-01667" ref-type="bibr">101</xref>]. All the toxic elements in the included studies were under the maximum limited level listed in the Pharmacopeia of the People&#x02019;s Republic of China [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>,<xref rid="B15-ijms-20-01667" ref-type="bibr">15</xref>,<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>,<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>,<xref rid="B52-ijms-20-01667" ref-type="bibr">52</xref>,<xref rid="B53-ijms-20-01667" ref-type="bibr">53</xref>,<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>,<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>,<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>,<xref rid="B74-ijms-20-01667" ref-type="bibr">74</xref>].</p></sec><sec id="sec3dot1dot6-ijms-20-01667"><title>3.1.6. Other Constituents</title><p>Apart from above chemical components, 33 chemical compounds belonging to six categories were isolated and identified, which are used for identification, as well as quality control, including two carbihydrates (&#x003b2;-<sc>d</sc>-glucose4-1&#x003b2;-<sc>d</sc>-galactose (D1) and sucrose (D2)) [<xref rid="B19-ijms-20-01667" ref-type="bibr">19</xref>], two sterols (&#x003b2;-sitosterol (E1) and daucosterol (E2)) [<xref rid="B68-ijms-20-01667" ref-type="bibr">68</xref>], 18 amino acids (glycine (F1), leucine (F2), methionine (F3), tyrosine (F4), histidine (F5), threonine (F6), alanine (F7), isoleucine (F8), tryptophan (F9), cystine (F10), lysine (F11), aspartic acid (F12), valine (F13), phenylalanine (F14), proline (F15), serine (F16), glutamic acid (F17) and arginine (F18)) [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>], four nucleobases (adenine (H1), hypoxanthine (H2), uracil (H3) and thymine (H4)) [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>,<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>], four fatty acids (vernolic acid (I1), 2-monopalmitin (I2), 13(R)-hydroxy-octadeca-(9Z,11E,15Z)-trien-oic acid (I3) and picropodophyllotoxin (I4)) [<xref rid="B67-ijms-20-01667" ref-type="bibr">67</xref>,<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>], and three lgnans (octahydrocurcumin (J1), zhebeiresinol (J2) and sauriol B (J3)) [<xref rid="B30-ijms-20-01667" ref-type="bibr">30</xref>,<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>].</p></sec></sec><sec id="sec3dot2-ijms-20-01667"><title>3.2. Pharmacology of FTB</title><p>There are 23 studies focused on the pharmacological effects of FTB, including anti-cancer, tracheobronchial relaxation, antitussive, expectorant, anti-muscarinic, anti-inflammation, anti-thyroid, regulation of blood rheology, antiulcer, anti-diarrhea, pain suppression, antioxidation and neuroprotection (<xref ref-type="fig" rid="ijms-20-01667-f003">Figure 3</xref>). Characteristics of the 23 included pharmacological effects are summarized in <xref rid="ijms-20-01667-t002" ref-type="table">Table 2</xref>.</p><sec id="sec3dot2dot1-ijms-20-01667"><title>3.2.1. Anti-Cancer Effect</title><p>Cancer is one of the most life-threatening conditions with high morbidity and mortality in the world [<xref rid="B102-ijms-20-01667" ref-type="bibr">102</xref>]. However, the therapeutic effects of conventional medicine are unsatisfactory, due to many adverse effects, such as fatigue, nausea and vomiting [<xref rid="B103-ijms-20-01667" ref-type="bibr">103</xref>]. Increasingly, natural products have been identified with anti-cancer activity, which may be associated with better therapeutic effects and less adverse effects [<xref rid="B104-ijms-20-01667" ref-type="bibr">104</xref>,<xref rid="B105-ijms-20-01667" ref-type="bibr">105</xref>]. Four included studies indicated that FTB had anti-cancer effect [<xref rid="B9-ijms-20-01667" ref-type="bibr">9</xref>,<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>,<xref rid="B80-ijms-20-01667" ref-type="bibr">80</xref>,<xref rid="B91-ijms-20-01667" ref-type="bibr">91</xref>]. Three of them investigated the multidrug resistance (MDR) reversal activity of FTB on human lung adenocarcinoma parental cells A549 [<xref rid="B80-ijms-20-01667" ref-type="bibr">80</xref>], human hepatocellular carcinoma cell line HepG2 [<xref rid="B9-ijms-20-01667" ref-type="bibr">9</xref>], and human breast carcinoma cells MCF-7 [<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>]. Li and colleagues reported that the total alkaloids of FTB may have the MDR reversal activity on A549/cisplatin (A549/DDP) cells [<xref rid="B80-ijms-20-01667" ref-type="bibr">80</xref>]. Specifically, the 50% inhibitory concentration (IC50) of FTB extract in vitro was 141 &#x000b1; 5 mg/L (A549 cells) and 298 &#x000b1; 22 mg/L (A549/DDP cells) while the IC50 DDP plus FTB (9 mg/L) and DDP alone on A549/DDP cells was 14.06 &#x000b1; 3.72 mg/L and 0.79 &#x000b1; 0.14 mg/L respectively after 72-h intervention. The reversal fold (RF) of FTB to DDP on A549/DDP cells was 17.80, higher than other reversal agents, such as cyclosporine A (10.16) and tetrandrine (14.05). The tumor inhibitory rate of DDP plus FTB (2 mg/kg) was 67.4%, higher than DDP alone (49.9%). The expressions of MDR1 mRNA and P-glycoprotein (P-gp) were significantly decreased by FTB extract. Similar results on the expression of P-gp were also reported by another research team in China [<xref rid="B9-ijms-20-01667" ref-type="bibr">9</xref>]. They used the Calcein-AM Kit to identify potential P-gp inhibitors. The results showed that alkaloids and nucleoside in FTB significantly restricted the efflux activity of P-gp in a dosage-dependent manner. Furthermore, Tong specified that peimine (A1) and peiminine (A2) were the reversal agents in FTB that reversed the MDR of adriamycin or paclitaxel in MCF7/A cells. The RF of peimine (A1) plus adriamycin or paclitaxel and peiminine (A2) plus adriamycin or paclitaxel was 8.17, 4.57, 3.30 and 3.73 respectively after 48-h treatment. In addition, direct anti-cancer activity was also detected by in vitro and In vivo studies in one included study [<xref rid="B91-ijms-20-01667" ref-type="bibr">91</xref>]. The researchers believed that the FTB aqueous extract (75 mg/mL) inhibited the human lung adenocarcinoma parental cells LM2 with dosage dependence and the apoptosis rate was increased over time (24 h: 5.7 &#x000b1; 0.91%; 48 h: 11.7 &#x000b1; 1.07%). In vivo studies revealed that the tumor inhibitory rate of FTB aqueous extract (1.6 g/kg) was 33.33%. Concurrently, the same dose of FTB aqueous extract significantly reduced the number of metastases in mice (5.7 &#x000b1; 1.72), compared to the control groups (7.3 &#x000b1; 2.2) [<xref rid="B91-ijms-20-01667" ref-type="bibr">91</xref>]. FTB, especially peimine (A1) and peiminine (A2), seems to have both direct and indirect anti-cancer effects evidenced by inhibiting the growth of tumor cells, as well as reversing the MDR of conventional chemotherapy drugs, such as DDP, adriamycin and paclitaxel [<xref rid="B9-ijms-20-01667" ref-type="bibr">9</xref>,<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>,<xref rid="B80-ijms-20-01667" ref-type="bibr">80</xref>,<xref rid="B91-ijms-20-01667" ref-type="bibr">91</xref>]. Nonetheless, existing evidence is not sufficient to elucidate its mechanisms of actions on lung, liver or breast cancer. Therefore, more in vitro and In vivo studies are needed on lung, liver, breast and other cancers to thoroughly investigate its direct and indirect anti-cancer activity in the future.</p></sec><sec id="sec3dot2dot2-ijms-20-01667"><title>3.2.2. Tracheobronchial Relaxation</title><p>Two included studies investigated the tracheobronchial relaxation activity of FTB extract in isolated bronchial and tracheal rings of rats [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>,<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>]. Chan claimed that peimine (A1), peiminine (A2), ebeiedine (A5), and puqietinone (A13) extracted from FTB relaxed the tracheobronch in vitro with 6.9 &#x000b1; 0.1, 6.4 &#x000b1; 0.12, 6.3 &#x000b1; 0.09 and 5.7 &#x000b1; 0.07 bronchi pD<sub>2</sub> values respectively and 6.9 &#x000b1; 0.12, 6.8 &#x000b1; 0.18, 6.5 &#x000b1; 0.08 and 6.0 &#x000b1; 0.16 tracheas pD<sub>2</sub> values [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>]. pD<sub>2</sub> values, also called pEC<sub>50</sub>, is the negative logarithm of the half maximal effective concentration (EC<sub>50</sub>) and if the pEC<sub>50</sub> values are larger, the drugs are more effective [<xref rid="B106-ijms-20-01667" ref-type="bibr">106</xref>]. Thus, the ranking order of effects within these compounds are peimine (A1) &#x02265; peiminine (A2) &#x0003e; ebeiedine (A5) &#x0003e; puqietinone (A13) [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>]. The researcher believed that the mechanisms of action of tracheobronchial relaxation activity of FTB may be related to activation of Ca<sup>2+</sup>-activated K<sup>+</sup> channels, since peimine (A1), peiminine (A2) and ebeiedine (A5) inhibited Ca<sup>2+</sup>-induced contraction (concentration: 3 mM Ca<sup>2+</sup>) during the study [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>]. Another recent study also investigated the pD<sub>2</sub> values of FTB on tracheobronchial relaxation activity [<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>]. The results indicated that the total alkaloids of FTB have tracheobronchial relaxation activity with 6.66 &#x000b1; 0.06 bronchi pD<sub>2</sub> values and 6.71 &#x000b1; 0.03 tracheas pD<sub>2</sub> values, significantly higher than the crude water extract (4.7 &#x000b1; 0.07 bronchi pD<sub>2</sub> values and 4.63 &#x000b1; 0.14 tracheas pD2 values) [<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>]. These two studies indicated that FTB could have tracheobronchial relaxation activity, due to its alkaloids, such as peimine (A1), peiminine (A2), ebeiedine (A5) and puqietinone (A13) [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>,<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>]. However, more solid evidence is required to identify the best treatment dosage of these compounds, as well as the effects of other alkaloids on tracheobronchial relaxation activity.</p></sec><sec id="sec3dot2dot3-ijms-20-01667"><title>3.2.3. Antitussive Effect</title><p>Two In vivo studies were conducted by the same research team to identify the antitussive effect of FTB in guinea pigs [<xref rid="B89-ijms-20-01667" ref-type="bibr">89</xref>,<xref rid="B90-ijms-20-01667" ref-type="bibr">90</xref>]. Both of them indicated that the frequency of cough was significantly reduced (15 &#x000b1; 7.6/5 min) and the remission period was prolonged (73.65 &#x000b1; 43.02 t/s) to five minutes after oral administration of micro powders of FTB, compared to the purified water control group (24.2 &#x000b1; 10.75/5 min and 46.99 &#x000b1; 12.02 t/s respectively) [<xref rid="B89-ijms-20-01667" ref-type="bibr">89</xref>,<xref rid="B90-ijms-20-01667" ref-type="bibr">90</xref>]. Another study compared the antitussive effects of FTB in mice harvested in four different places in China [<xref rid="B27-ijms-20-01667" ref-type="bibr">27</xref>]. The results indicated that a high dose of FTB aqueous extract (0.104 g/kg) harvested in all four different places significantly reduced the frequency of cough (<italic>p</italic> &#x0003c; 0.01) and increased the remission period (<italic>p</italic> &#x0003c; 0.05) [<xref rid="B27-ijms-20-01667" ref-type="bibr">27</xref>]. As an important antitussive herb in ancient China, micro powders and aqueous extract of FTB appeared to have antitussive activity in experimental studies.</p></sec><sec id="sec3dot2dot4-ijms-20-01667"><title>3.2.4. Expectorant Effect</title><p>Two studies described FTB&#x02019;s expectorant effect [<xref rid="B86-ijms-20-01667" ref-type="bibr">86</xref>,<xref rid="B89-ijms-20-01667" ref-type="bibr">89</xref>]. Yan and colleagues evaluated the expectorant effects of FTB fine powders via the phenol red expectoration test [<xref rid="B89-ijms-20-01667" ref-type="bibr">89</xref>]. The results indicated that FTB fine powders significantly reduced the amount of phlegm secretion (phenol red contraction: 1.048 &#x000b1; 0.09 mg/L), compared to the blank control group (phenol red contraction: 0.691 &#x000b1; 0.059 mg/L) (mean difference 0.36, 95% confidence interval 0.29&#x02013;0.42) [<xref rid="B89-ijms-20-01667" ref-type="bibr">89</xref>]. The other study assessed the amount of phlegm secretion using a percentage (per hour secretion before and after administration) [<xref rid="B86-ijms-20-01667" ref-type="bibr">86</xref>]. The result showed that FTB dramatically reduced the amount of phlegm secretion (203.6%, larger than the standard 170% which indicates effective treatment), compared to the control group (101.2%) [<xref rid="B86-ijms-20-01667" ref-type="bibr">86</xref>]. These two studies showed that the fine powders and alcohol extract of FTB produce the expectorant effect evidenced by decreasing the amount of phlegm secretion [<xref rid="B86-ijms-20-01667" ref-type="bibr">86</xref>,<xref rid="B89-ijms-20-01667" ref-type="bibr">89</xref>]. However, the active compounds related to this effect are still unknown. Further studies should investigate the active chemical constituents in FTB, as well as possible mechanisms of actions related to the expectorant effect.</p></sec><sec id="sec3dot2dot5-ijms-20-01667"><title>3.2.5. Anti-inflammation</title><p>Anti-inflammation is one of the most essential pharmacological effects of FTB, mentioned in five included studies, three in vitro studies [<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>,<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>,<xref rid="B88-ijms-20-01667" ref-type="bibr">88</xref>] and two In vivo studies [<xref rid="B87-ijms-20-01667" ref-type="bibr">87</xref>,<xref rid="B93-ijms-20-01667" ref-type="bibr">93</xref>]. Three chemical compounds isolated from FTB, including peimine (A1), ebeiedine (A5) and suchengbeisine (A8), could reduce the expression and production of MUC5AC mucin (common mucin expressed in the airway surface epithelium) in human pulmonary mucoepidermoid NCI-H292 cells [<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>]. Peimine (A1) was able to block the Kv1.3 ion channel [<xref rid="B88-ijms-20-01667" ref-type="bibr">88</xref>]. The Kv1.3 inhibitor is commonly believed to have the anti-inflammatory ability, blocking the human T lymphocytes-induced immune responses [<xref rid="B88-ijms-20-01667" ref-type="bibr">88</xref>,<xref rid="B107-ijms-20-01667" ref-type="bibr">107</xref>,<xref rid="B108-ijms-20-01667" ref-type="bibr">108</xref>]. Another five chemical compounds, including isoverticine (A7), puqiedine (A15), N-demethylpuqietinone (A19), 2-monopalmitin (I2), and zhebeiresinol (J2) reduced the expression of NF-&#x003ba;B level in the human embryonic kidney cells HEK293 [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]. In vivo studies revealed that the aqueous extract of FTB inhibited the abnormal immune response by relieving the inflammation and over the proliferation of fibroblasts of the prostate, as well as reducing the serum level of NO in the mice model with immunological chronic prostatitis/chronic pelvic pain syndrome [<xref rid="B87-ijms-20-01667" ref-type="bibr">87</xref>]. Two animal studies reported that the alcohol extract of FTB relieved the swelling of ear and foot plantar induced by xylene and carrageenin respectively in mice [<xref rid="B93-ijms-20-01667" ref-type="bibr">93</xref>]. With its anti-inflammatory activities, FTB could be used for many inflammatory disorders, such as pulmonary or tracheobronchial inflammatory disorders, lump or masses [<xref rid="B87-ijms-20-01667" ref-type="bibr">87</xref>,<xref rid="B93-ijms-20-01667" ref-type="bibr">93</xref>]. Future studies should focus on mechanisms of actions of the active compounds mentioned in these publications, including peimine (A1), ebeiedine (A5) and suchengbeisine (A8), isoverticine (A7), puqiedine (A15), N-demethylpuqietinone (A19), 2-monopalmitin (I2), and zhebeiresinol (J2) for anti-inflammatory activity.</p></sec><sec id="sec3dot2dot6-ijms-20-01667"><title>3.2.6. Pain Suppression</title><p>FTB was found to be a potential pain reliever in two included studies [<xref rid="B88-ijms-20-01667" ref-type="bibr">88</xref>,<xref rid="B92-ijms-20-01667" ref-type="bibr">92</xref>]. Peimine (A1) extracted from FTB inhibited the Nav1.7 ion channel, which could be a possible mechanism of action of pain suppression [<xref rid="B88-ijms-20-01667" ref-type="bibr">88</xref>]. Nav1.7, commonly found in the peripheral nervous system, is one number of the sodium channel family encoded by the SCN9A gene [<xref rid="B109-ijms-20-01667" ref-type="bibr">109</xref>,<xref rid="B110-ijms-20-01667" ref-type="bibr">110</xref>,<xref rid="B111-ijms-20-01667" ref-type="bibr">111</xref>]. Blocking this channel may lead to inherited gene mutations and subsequently lead to pain sensory loss [<xref rid="B112-ijms-20-01667" ref-type="bibr">112</xref>]. The alcohol extract of FTB reduced the frequency of mouse writhing (acetic acid induced pain test) and prolonged the remission period of tail-flick latency (thermal stimulus pain test) in mice [<xref rid="B92-ijms-20-01667" ref-type="bibr">92</xref>]. The in vitro and in vivo studies mentioned above presented some evidence relevant to the pain suppressive activity of FTB. However, due to limited evidence, it is difficult to thoroughly explain the mechanisms of this action. Further studies could consider using peimine (A1) as an active compound for pain relief in in vitro and in vivo studies.</p></sec><sec id="sec3dot2dot7-ijms-20-01667"><title>3.2.7. Antioxidation</title><p>Recent studies indicated that many herbs, including FTB have an antioxidative effect [<xref rid="B84-ijms-20-01667" ref-type="bibr">84</xref>,<xref rid="B85-ijms-20-01667" ref-type="bibr">85</xref>]. The total alkaloids extracted from FTB has strong antioxidative capacity that was reflected in the data of 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity (EC<sub>50</sub>: 5.5 mg/mL), 2,2&#x02032;-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) radical scavenging activity (EC<sub>50</sub>: 0.3 mg/mL) and ferric reducing capacity test (118.2 mg ascorbic acid equivalent per 100 g) [<xref rid="B85-ijms-20-01667" ref-type="bibr">85</xref>]. The polysaccharide extracted from FTB also has an antioxidative effect [<xref rid="B84-ijms-20-01667" ref-type="bibr">84</xref>]. Specifically, the DPPH scavenging ratio of FTB was 21.46%. The reducing capacity and total antioxidative capacity of FTB polysaccharide (1 mg/mL) were evaluated using the absorption spectroscopy method (700 nm) with 0.51 and 0.39 absorbance respectively [<xref rid="B84-ijms-20-01667" ref-type="bibr">84</xref>]. Notwithstanding the fact that both of the in vitro studies indicated that not only total alkaloids, but also polysaccharide in FTB have a strong antioxidative capacity, in vivo studies are needed to support in vitro findings in future. In addition, identifying the active compounds related to this pharmacological effect is required.</p></sec><sec id="sec3dot2dot8-ijms-20-01667"><title>3.2.8. Other Pharmacological Effects</title><p>FTB also had other pharmacological effects, including anti-ulcer, anti-muscarinic, anti-thyroid, regulation of blood rheological properties, anti-diarrhea and neuroprotection [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>,<xref rid="B75-ijms-20-01667" ref-type="bibr">75</xref>,<xref rid="B78-ijms-20-01667" ref-type="bibr">78</xref>,<xref rid="B82-ijms-20-01667" ref-type="bibr">82</xref>,<xref rid="B92-ijms-20-01667" ref-type="bibr">92</xref>,<xref rid="B93-ijms-20-01667" ref-type="bibr">93</xref>,<xref rid="B94-ijms-20-01667" ref-type="bibr">94</xref>]. The alcohol extract of FTB could directly inhibit water immersion-induced or hydrochloric acid-induced gastric ulcer [<xref rid="B92-ijms-20-01667" ref-type="bibr">92</xref>], as well as an acetic acid-induced oral ulcer in rats [<xref rid="B94-ijms-20-01667" ref-type="bibr">94</xref>]. Three alkaloids, including peimine (A1), peiminine (A2) and puqietinone (A13), could significantly increase the cAMP level in the HEK293 cells transfected with muscarinic M2 receptor [<xref rid="B75-ijms-20-01667" ref-type="bibr">75</xref>]. Anti-thyroid activity was detected, evidenced by reduced the serum levels of T<sub>3</sub>, T<sub>4</sub>, cAMP and cGMP, and increasing hypoxia tolerance in hyperthyroidic mice [<xref rid="B82-ijms-20-01667" ref-type="bibr">82</xref>]. FTB was able to decrease whole blood viscosity, inhibit erythrocyte aggregation and increase erythrocyte deformability in rats, which means it could regulate blood rheological properties [<xref rid="B78-ijms-20-01667" ref-type="bibr">78</xref>]. In addition, the alcohol extract of FTB significantly decreased the frequency of diarrhea induced by castor oil or Fan xie ye (<italic>Folium Sennae</italic>) [<xref rid="B93-ijms-20-01667" ref-type="bibr">93</xref>]. The NO level in lipopolysaccharide-activated BV-2 cells was inhibited by ebeiedinone (A6) (IC<sub>50</sub>: 11.45 &#x003bc;M), suchengbeisine (A8) (IC50: 18.02 &#x003bc;M) and frithunbol B (A24) (IC<sub>50</sub>: 16.35 &#x003bc;M) [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]. Moreover, the compound 3&#x003b2;-hydroxy-5&#x003b1;-jervanin-12-en-6-one (A26) significantly increased the nerve growth factor level (134.81 &#x000b1; 3.66%) in C6 glioma cells [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]. In vivo and in vitro studies demonstrated that FTB may have a series of pharmacological effects. However, evidence for each pharmacological effect of FTB is limited. More in vitro and in vivo studies are needed to elucidate the possible mechanisms of actions of each effect.</p></sec></sec><sec id="sec3dot3-ijms-20-01667"><title>3.3. Pharmacokinetics of FTB</title><p>Only six included studies of this review provided information on the pharmacokinetics of FTB&#x02019;s chemical compounds, such as peimine (A1), peiminine (A2) and peimisine (A9) [<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>,<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>,<xref rid="B59-ijms-20-01667" ref-type="bibr">59</xref>,<xref rid="B76-ijms-20-01667" ref-type="bibr">76</xref>,<xref rid="B77-ijms-20-01667" ref-type="bibr">77</xref>,<xref rid="B83-ijms-20-01667" ref-type="bibr">83</xref>]. The experimental study indicated that peiminine (A2), extracted by 70% or 90% ethyl alcohol, could penetrate excised rat skin using ultraviolet radiation testing method [<xref rid="B83-ijms-20-01667" ref-type="bibr">83</xref>]. The penetration rates were similar in both concentrations of solvent. Although the penetration amount of peiminine (A2) in different concentrations of ethyl alcohol was similar and increased over time, the percutaneous permeability coefficient was limited and low in both groups. A sensitive, rapid and maneuverable method, LC-TRAP-MS, was developed to identify whether the nine alkaloids extracted from FTB could be absorbed by rats in plasma after oral administration [<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>]. The study claimed that six compounds, including peimine (A1), peiminine (A2), ebeiedinone (A6), isoverticine (A7), peimisine (A9), and puqiedinone (A14) were detected in plasma whereas three of them, including ebeiedine (A5), zhebeininoside (A11) and puqiedine (A15) were not. Furthermore, the parameters of pharmacokinetics of peimine (A1), peiminine (A2) and peimisine (A9) were investigated in four studies, including maximum concentration (C<sub>max</sub>), elimination half-life (T<sub>1/2</sub>), time to reach C<sub>max</sub> (T<sub>max</sub>), oral clearance (CL/F), volume distribution/bioavailability (V/F), area under the concentration-time curve (AUC) from zero to t and from zero to infinite time [<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>,<xref rid="B59-ijms-20-01667" ref-type="bibr">59</xref>,<xref rid="B76-ijms-20-01667" ref-type="bibr">76</xref>,<xref rid="B77-ijms-20-01667" ref-type="bibr">77</xref>]. <xref rid="ijms-20-01667-t003" ref-type="table">Table 3</xref> summarizes the pharmacokinetic parameters of peimine (A1), peiminine (A2) and peimisine (A9) in these four studies. </p><p>One of these four studies compared the differences of pharmacokinetics, tissue distribution and excretion between male and female rats [<xref rid="B77-ijms-20-01667" ref-type="bibr">77</xref>]. <xref rid="ijms-20-01667-t003" ref-type="table">Table 3</xref> shows that in this study, the index (Cmax, Tmax, AUC0-t and AUC0-&#x0221e;) of male rats was significantly higher than the female&#x02019;s while the CL/F and V/F statistics were lower, which indicates that the elimination of peimine and peiminine in male rat plasma was slower than the female&#x02019;s (<italic>p</italic> &#x0003c; 0.05). In contrast, the results also showed that the cumulative excretion of peimine (A1) and peiminine (A2) in male rat urine were significantly higher than that in female. Additionally, peimine (A1) and peiminine (A2) were found in various tissues of rats, including liver, heart, spleen, kidney, lung, uterus, ovary, brain, testis, muscle and skin [<xref rid="B77-ijms-20-01667" ref-type="bibr">77</xref>]. The concentrations of both alkaloids in male tissues were significantly higher than female&#x02019;s, except for muscle and skin. On the other hand, the pharmacokinetic parameters in Tong&#x02019;s study were substantially lower than those in the other three studies, and this may be due to its very low administration dose (0.45 g/kg) [<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>]. Current pharmacokinetic studies of FTB are mainly focused on the absorption, distribution and excretion of peimine (A1), peiminine (A2) and some other alkaloids in rats. The examination of other chemical compounds will assist in understanding the pharmacokinetic profile of FTB. Further research should consider comprehensively investigating the pharmacokinetics of other chemical components listed in <xref rid="ijms-20-01667-t001" ref-type="table">Table 1</xref>.</p></sec><sec id="sec3dot4-ijms-20-01667"><title>3.4. Toxicity of FTB</title><p>FTB is considered a non-toxic or low toxic herb for the past several thousands of years with a recommended dose of 5&#x02212;10 g (equivalent to 83&#x02013;167 mg/kg body weight) for adults [<xref rid="B2-ijms-20-01667" ref-type="bibr">2</xref>]. Recently, three included studies were published which are relevant to the toxicity of FTB [<xref rid="B79-ijms-20-01667" ref-type="bibr">79</xref>,<xref rid="B81-ijms-20-01667" ref-type="bibr">81</xref>,<xref rid="B92-ijms-20-01667" ref-type="bibr">92</xref>]. An in vivo study using 110 male Wistar rats indicated that the FTB water extract (10 g/kg, ig, for seven days) did not increase the creatine kinase and lactate dehydrogenase levels compared to the saline group [<xref rid="B79-ijms-20-01667" ref-type="bibr">79</xref>]. The histopathological examination in this study showed that the basic structure of heart tissue and cardiac muscle fibers were normal, compared to the saline group. This revealed that the extract of FTB did not induce cardiotoxicity in rats. Nonetheless, irregular cell nuclear arrangement and nonuniform cytoplasm staining were found in the FTB group.</p><p>Another two studies investigated the median lethal dose (LD<sub>50</sub>) of oral intake FTB extract on 40 and 60 mice respectively via the acute toxicity test for seven [<xref rid="B92-ijms-20-01667" ref-type="bibr">92</xref>] and 14 days [<xref rid="B81-ijms-20-01667" ref-type="bibr">81</xref>] respectively. The results showed that the LD<sub>50</sub> was 12.2 &#x000b1; 2.2 g/kg [<xref rid="B92-ijms-20-01667" ref-type="bibr">92</xref>] and 53 mg/kg [<xref rid="B81-ijms-20-01667" ref-type="bibr">81</xref>] on mice respectively. Due to insufficient information, it is difficult to interpret the dramatic difference of the LD<sub>50</sub> between these two studies. Acute toxic symptoms were observed, such as tremors, restlessness, drowsiness, asthma, convulsions, urinary incontinence, and tail-erecting reaction, and the cause of death could be pulmonary venous pleonaemia and respiratory failure [<xref rid="B81-ijms-20-01667" ref-type="bibr">81</xref>,<xref rid="B92-ijms-20-01667" ref-type="bibr">92</xref>]. A sub-chronic toxicity test was conducted on 120 rats after oral-intake of 1 or 3 mg/kg FTB extract for 26 weeks [<xref rid="B81-ijms-20-01667" ref-type="bibr">81</xref>]. The findings indicated that the safe dose of FTB extract could be 1 mg/kg without any toxicity symptoms whereas tremor and reduction of spontaneous motor activities were found in the 3 mg/kg group. Furthermore, hematology, blood biochemistry, as well as weight and histology of rats&#x02019; organ were observed without any significant changes within 26 weeks [<xref rid="B81-ijms-20-01667" ref-type="bibr">81</xref>].</p><p>The recommended dose listed in the Pharmacopeia of the People&#x02019;s Republic of China seems to be safe, as the aqueous extract of FTB in recommended dose could be 0.0415&#x02013;0.0835 mg/kg (0.05% extraction efficiency), which is approximately 10&#x02013;25 times lower than 1 mg/kg [<xref rid="B81-ijms-20-01667" ref-type="bibr">81</xref>]. Nonetheless, some challenges should not be neglected, such as the tremendous difference of LD<sub>50</sub> in two different studies and the adverse effects found in the animal studies. Therefore, more experimental and clinical toxicity studies are needed, with a focus on the estimation of LD<sub>50</sub>, as well as the adverse effects of FTB at both low and high doses.</p></sec></sec><sec sec-type="conclusions" id="sec4-ijms-20-01667"><title>4. Conclusions</title><p>It is worth noting that this study was the first to systematically review the traditional uses, phytochemistry, pharmacodynamics, pharmacokinetics and toxicity of FTB. The crude herb FTB contains more than 100 chemical constituents in 11 categories with 13 possible pharmacological activities. Included studies revealed that these pharmacological activities may be mainly attributed to the alkaloids isolated from FTB. Its multiple compounds and effects may contribute to novel drug discovery for the management of multiple conditions. Current studies indicated that additional or even synergistic therapeutic effects could be produced, and may be superior to a single component, when combined multiple active constituents are used, because of the concurrent and selective interactions with multiple target proteins of a disease or a condition, such as malignant tumor, respiratory disorders and inflammation. Classic literature also suggested that there are multiple actions which may be performed by FTB. However, the mechanisms of actions of FTB are still not clear. The relationship between active chemical constituents and possible mechanisms needed to be systematically evaluated as well. High quality and well-designed in vivo and in vitro studies on the mechanisms of actions, pharmacokinetic and toxicity of FTB are recommended. A comprehensive and thorough investigation of the multi-target network pharmacology of FTB could provide insights into various conditions, and thus support evidence-based practice.</p></sec></body><back><app-group><app id="app1-ijms-20-01667"><title>Supplementary Materials</title><p>Supplementary materials can be found at <uri xlink:href="https://www.mdpi.com/1422-0067/20/7/1667/s1">https://www.mdpi.com/1422-0067/20/7/1667/s1</uri>.</p><supplementary-material content-type="local-data" id="ijms-20-01667-s001"><media xlink:href="ijms-20-01667-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors have no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-20-01667"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bensky</surname><given-names>D.</given-names></name><name><surname>Clavey</surname><given-names>S.</given-names></name><name><surname>St&#x000f6;ger</surname><given-names>E.</given-names></name></person-group><source>Chinese Herbal Medicine. Materia Medica</source><edition>3rd ed.</edition><publisher-name>Eastland Press</publisher-name><publisher-loc>Seattle, WA, USA</publisher-loc><year>2015</year></element-citation></ref><ref id="B2-ijms-20-01667"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="editor"><collab>Chinese Pharmacopoeia Commission</collab></person-group><source>Pharmacopoeia of the People&#x02019;s Republic of China</source><publisher-name>China Medical Science and Technology Press</publisher-name><publisher-loc>Beijing, China</publisher-loc><year>2015</year><volume>Volume 1</volume></element-citation></ref><ref id="B3-ijms-20-01667"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Hung</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>A.W.H.</given-names></name></person-group><article-title>A Classic Herbal Formula Danggui Beimu Kushen Wan for Chronic Prostatitis: From Traditional Knowledge to Scientific Exploration</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2018</year><volume>2018</volume><fpage>1612948</fpage><pub-id pub-id-type="doi">10.1155/2018/1612948</pub-id></element-citation></ref><ref id="B4-ijms-20-01667"><label>4.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Wiseman</surname><given-names>N.</given-names></name><name><surname>Wilms</surname><given-names>S.</given-names></name></person-group><source>Jin Gui Yao Lue: Essential Prescriptions of the Golden Cabinet</source><publisher-name>Paradigm Publications</publisher-name><publisher-loc>Taos, NM, USA</publisher-loc><year>2013</year></element-citation></ref><ref id="B5-ijms-20-01667"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.Y.</given-names></name><name><surname>Bai</surname><given-names>X.Y.</given-names></name><name><surname>Wang</surname><given-names>C.H.</given-names></name></person-group><article-title>Traditional Chinese medicine: A treasured natural resource of anticancer drug research and development</article-title><source>Am. J. Chin. Med.</source><year>2014</year><volume>42</volume><fpage>543</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1142/S0192415X14500359</pub-id><?supplied-pmid 24871650?><pub-id pub-id-type="pmid">24871650</pub-id></element-citation></ref><ref id="B6-ijms-20-01667"><label>6.</label><element-citation publication-type="book"><person-group person-group-type="editor"><collab>Jiangsu New Medical Academy</collab></person-group><source>Zhong Yao Da Ci Dian [Great Compendium of Chinese Medicines]</source><publisher-name>Shanghai Scientific and Technical Publishers</publisher-name><publisher-loc>Shanghai, China</publisher-loc><year>1994</year></element-citation></ref><ref id="B7-ijms-20-01667"><label>7.</label><element-citation publication-type="book"><person-group person-group-type="editor"><collab>State Administration of Traditional Chinese Medicine &#x02018;Chinese Materia Medica Committee&#x02019;</collab></person-group><source>Zhong Hua Ben Cao [Chinese Materia Medica]</source><publisher-name>Shanghai Scientific and Technical Publishers</publisher-name><publisher-loc>Shanghai, China</publisher-loc><year>1999</year></element-citation></ref><ref id="B8-ijms-20-01667"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>W.S.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Park</surname><given-names>J.E.</given-names></name><name><surname>Kim</surname><given-names>D.H.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name></person-group><article-title>Two new steroidal alkaloids from the bulbs of fritillaria thunbergii</article-title><source>Heterocycles</source><year>2018</year><volume>96</volume><fpage>921</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.3987/COM-18-13891</pub-id></element-citation></ref><ref id="B9-ijms-20-01667"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Zou</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name></person-group><article-title>Studies on P-glycoprotein inhibitor of multidrug tumor in Bulbus Fritillariae Thunbergii</article-title><source>Chin. J. Surg. Integr. Tradit. West. Med.</source><year>2015</year><volume>21</volume><fpage>379</fpage><lpage>382</lpage></element-citation></ref><ref id="B10-ijms-20-01667"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>China Association of Chinese Medicine</collab></person-group><source>Zhong Hua Yi Dian (Encyclopaedia of Traditional Chinese Medicine) [CD-ROM]</source><edition>5th ed.</edition><publisher-name>Hunan Electronic and Audio-Visual Publishing House</publisher-name><publisher-loc>Changsha, China</publisher-loc><year>2015</year></element-citation></ref><ref id="B11-ijms-20-01667"><label>11.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>Chinese Medicine Board of Australia</collab></person-group><article-title>Nomenclature List of Commonly Used Chinese Herbal Medicines</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.chinesemedicineboard.gov.au/documents/default.aspx?record=WD15%2f18746&#x00026;dbid=AP&#x00026;chksum=Cs%2baCFhYVrzbzL2%2bYnhtRA%3d%3d">http://www.chinesemedicineboard.gov.au/documents/default.aspx?record=WD15%2f18746&#x00026;dbid=AP&#x00026;chksum=Cs%2baCFhYVrzbzL2%2bYnhtRA%3d%3d</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-01-22">(accessed on 22 January 2019)</date-in-citation></element-citation></ref><ref id="B12-ijms-20-01667"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Culley</surname><given-names>T.M.</given-names></name></person-group><article-title>Why vouchers matter in botanical research</article-title><source>Appl. Plant Sci.</source><year>2013</year><volume>1</volume><fpage>1300076</fpage><pub-id pub-id-type="doi">10.3732/apps.1300076</pub-id><?supplied-pmid 25202501?><pub-id pub-id-type="pmid">25202501</pub-id></element-citation></ref><ref id="B13-ijms-20-01667"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreiner</surname><given-names>J.</given-names></name><name><surname>Pang</surname><given-names>E.</given-names></name><name><surname>Lenon</surname><given-names>G.B.</given-names></name><name><surname>Yang</surname><given-names>A.W.H.</given-names></name></person-group><article-title>Saposhnikoviae divaricata: A phytochemical, pharmacological, and pharmacokinetic review</article-title><source>Chin. J. Nat. Med.</source><year>2017</year><volume>15</volume><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/S1875-5364(17)30042-0</pub-id><pub-id pub-id-type="pmid">28527510</pub-id></element-citation></ref><ref id="B14-ijms-20-01667"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>W.</given-names></name><name><surname>Xiong</surname><given-names>Y.</given-names></name><name><surname>Sheng</surname><given-names>Z.</given-names></name><name><surname>Xia</surname><given-names>M.</given-names></name><name><surname>Cui</surname><given-names>M.</given-names></name></person-group><article-title>Determination of eighteen trace elements in Fritillaria from different places by ICP-OES</article-title><source>Chin. J. Mod. Appl. Pharm.</source><year>2013</year><volume>30</volume><fpage>277</fpage><lpage>280</lpage></element-citation></ref><ref id="B15-ijms-20-01667"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Du</surname><given-names>W.</given-names></name><name><surname>Sheng</surname><given-names>Z.</given-names></name><name><surname>Yin</surname><given-names>Z.</given-names></name><name><surname>Fang</surname><given-names>L.</given-names></name><name><surname>Cai</surname><given-names>B.</given-names></name><name><surname>Ge</surname><given-names>W.</given-names></name></person-group><article-title>Determination of heavy metal and trace elements in fresh-cut Bulbus Fritillaria thunbergii slices by ICP-OES</article-title><source>Chin. Arch. Tradit. Chin. Med.</source><year>2014</year><volume>32</volume><fpage>2357</fpage><lpage>2359</lpage></element-citation></ref><ref id="B16-ijms-20-01667"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Tan</surname><given-names>L.</given-names></name></person-group><article-title>Analysis of chemical composition by GC/MS and antimicrobial activities of essential oil from Fritillaria thunbergii Miq</article-title><source>J. Zhejiang Sci.-Tech. Univ.</source><year>2012</year><volume>29</volume><fpage>129</fpage><lpage>132</lpage></element-citation></ref><ref id="B17-ijms-20-01667"><label>17.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>S.W.</given-names></name></person-group><article-title>Pharmacological and Chemical Investigations into Bulbus Fritillariae</article-title><source>Ph.D. Thesis</source><publisher-name>Chinese University of Hong Kong</publisher-name><publisher-loc>Hong Kong, China</publisher-loc><year>2000</year></element-citation></ref><ref id="B18-ijms-20-01667"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Mao</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Miao</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name></person-group><article-title>Study on the effects of different drying methods on physicochemical properties, structure, and in vitro digestibility of Fritillaria thunbergii Miq. (Zhebeimu) flours</article-title><source>Food Bioprod. Process.</source><year>2016</year><volume>98</volume><fpage>266</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/j.fbp.2016.01.008</pub-id></element-citation></ref><ref id="B19-ijms-20-01667"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name></person-group><article-title>&#x003b2;-D-glu 4-1&#x003b2;-D-gal and sucrose determination of different Fritillarias by HPLC-ELSD</article-title><source>Lishizhen Med. Mater. Med. Res.</source><year>2012</year><volume>23</volume><fpage>1605</fpage><lpage>1606</lpage></element-citation></ref><ref id="B20-ijms-20-01667"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name></person-group><article-title>Disscussion on the necessity of preserving the bulb of Zhebeimu (Fritillariae thunbergii bulbus) based on modern chemical analysis</article-title><source>Guid. J. Tradit. Chin. Med. Pharm.</source><year>2016</year><volume>22</volume><fpage>44</fpage><lpage>46</lpage></element-citation></ref><ref id="B21-ijms-20-01667"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Xiao</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Ma</surname><given-names>S.</given-names></name></person-group><article-title>Determination the contents of peimine and peiminine in Thumberg Fritillary Bulb by HPLC-MS</article-title><source>China Pharm.</source><year>2008</year><volume>11</volume><fpage>770</fpage><lpage>772</lpage></element-citation></ref><ref id="B22-ijms-20-01667"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Ling</surname><given-names>Q.</given-names></name></person-group><article-title>Identification of alkaloids and flavonoids in all parts of Fritillaria thunbergii using LC-LTQ-Qrbitrap MS<sup>n</sup></article-title><source>Zhongguo Zhong Yao Za Zhi</source><year>2016</year><volume>41</volume><fpage>2124</fpage><lpage>2130</lpage><?supplied-pmid 28901111?><pub-id pub-id-type="pmid">28901111</pub-id></element-citation></ref><ref id="B23-ijms-20-01667"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>Q.</given-names></name></person-group><article-title>Studies on the effect on the quantities of alkaloids of Bulbs Fritillariae thunbergii in different menstruum</article-title><source>Lishizhen Med. Mater. Med. Res.</source><year>2001</year><volume>12</volume><fpage>779</fpage><lpage>780</lpage></element-citation></ref><ref id="B24-ijms-20-01667"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Fang</surname><given-names>K.</given-names></name></person-group><article-title>Contents mensuration of total alkaloid in Bulbus Fritillariae by acid dye colorinetry</article-title><source>China Pharma.</source><year>1999</year><volume>8</volume><fpage>46</fpage><lpage>47</lpage></element-citation></ref><ref id="B25-ijms-20-01667"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Yue</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>T.</given-names></name><name><surname>Ge</surname><given-names>W.</given-names></name></person-group><article-title>The analysis on volatile components of Zhejiang Fritillary slices with different primary processing methods</article-title><source>Lishizhen Med. Mater. Med. Res.</source><year>2018</year><volume>29</volume><fpage>73</fpage><lpage>76</lpage></element-citation></ref><ref id="B26-ijms-20-01667"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>B.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name></person-group><article-title>Study on the destructive effect to inherent quality of Fritillaria thunbergii Miq. (<italic>Zhebeimu</italic>) by sulfur-fumigated process using chromatographic fingerprinting analysis</article-title><source>Phytomedicine</source><year>2012</year><volume>19</volume><fpage>562</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2011.12.010</pub-id><pub-id pub-id-type="pmid">22326548</pub-id></element-citation></ref><ref id="B27-ijms-20-01667"><label>27.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>J.</given-names></name></person-group><article-title>Compariative Research on the Pharmaceutic and Pharmacodynamics among Different Breed Bulbus Fritillaria Thunbergii</article-title><source>Master&#x02019;s Thesis</source><publisher-name>Heilongjiang University of Chinese Medicine</publisher-name><publisher-loc>Haerbin, China</publisher-loc><year>2007</year></element-citation></ref><ref id="B28-ijms-20-01667"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.</given-names></name></person-group><article-title>Determination of the contents of peimine A and peimine B in Fritillaria thunbergii by ELSD</article-title><source>China Health Stand. Manag.</source><year>2016</year><volume>7</volume><fpage>139</fpage><lpage>141</lpage></element-citation></ref><ref id="B29-ijms-20-01667"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group><article-title>Determination of verticine and verticinone in Bulbus Fritillariae Thunbergii by HPLC-ELSD</article-title><source>Zhongguo Yao Xue Za Zhi</source><year>2005</year><volume>40</volume><fpage>1257</fpage><lpage>1259</lpage></element-citation></ref><ref id="B30-ijms-20-01667"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Cui</surname><given-names>D.</given-names></name><name><surname>Xiao</surname><given-names>X.</given-names></name><name><surname>Tian</surname><given-names>Z.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Zhen</surname><given-names>Q.</given-names></name></person-group><article-title>The structure identification of zhepiresionol</article-title><source>Acta Pharm. Sin.</source><year>1993</year><volume>28</volume><fpage>212</fpage><lpage>215</lpage></element-citation></ref><ref id="B31-ijms-20-01667"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Chao</surname><given-names>Z.</given-names></name><name><surname>Chao</surname><given-names>X.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name></person-group><article-title>Separation and purification of peimine and peiminine from Bulbus Fritillariae Thunbergi by high speed countercurrent chromatography</article-title><source>Res. Inf. Tradit. Chin. Med.</source><year>2005</year><volume>7</volume><fpage>13</fpage><lpage>15</lpage></element-citation></ref><ref id="B32-ijms-20-01667"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Zeng</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name></person-group><article-title>Effects of different soaking time on extraction of active components of Fritillary Bulb</article-title><source>China Pharm.</source><year>2012</year><volume>21</volume><fpage>24</fpage><lpage>25</lpage></element-citation></ref><ref id="B33-ijms-20-01667"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>E.J.</given-names></name><name><surname>Yoon</surname><given-names>Y.P.</given-names></name><name><surname>Woo</surname><given-names>K.W.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Min</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Lee</surname><given-names>S.K.</given-names></name><name><surname>Hong</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>K.R.</given-names></name><name><surname>Lee</surname><given-names>C.J.</given-names></name></person-group><article-title>Verticine, ebeiedine and suchengbeisine isolated from the bulbs of Fritillaria thunbergii Miq. inhibited the gene expression and production of MUC5AC mucin from human airway epithelial cells</article-title><source>Phytomedicine</source><year>2016</year><volume>23</volume><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2015.12.016</pub-id><?supplied-pmid 26926170?><pub-id pub-id-type="pmid">26926170</pub-id></element-citation></ref><ref id="B34-ijms-20-01667"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitajima</surname><given-names>J.</given-names></name><name><surname>Komori</surname><given-names>T.</given-names></name><name><surname>Kawasaki</surname><given-names>T.</given-names></name></person-group><article-title>Studies on the constituents of the crude drug &#x0201c;Fritillariae bulbus.&#x0201d; III. On the diterpenoid constituents of fresh bulbs of Fritillaria thunbergii Miq</article-title><source>Chem. Pharm. Bull.</source><year>1982</year><volume>30</volume><fpage>3912</fpage><lpage>3921</lpage><pub-id pub-id-type="doi">10.1248/cpb.30.3912</pub-id></element-citation></ref><ref id="B35-ijms-20-01667"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitajima</surname><given-names>J.</given-names></name><name><surname>Noda</surname><given-names>N.</given-names></name><name><surname>Ida</surname><given-names>Y.</given-names></name><name><surname>Komori</surname><given-names>T.</given-names></name><name><surname>Kawasaki</surname><given-names>T.</given-names></name></person-group><article-title>Studies on the constituents of the crude drug &#x0201c;Fritillariae bulbus.&#x0201d; IV. On the diterpenoid constituents of the crudr &#x0201c;Fritillariae bulbus&#x0201d;</article-title><source>Chem. Pharm. Bull.</source><year>1982</year><volume>30</volume><fpage>3922</fpage><lpage>3931</lpage><pub-id pub-id-type="doi">10.1248/cpb.30.3922</pub-id></element-citation></ref><ref id="B36-ijms-20-01667"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.L.</given-names></name><name><surname>Lin</surname><given-names>G.</given-names></name><name><surname>Chan</surname><given-names>S.W.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group><article-title>Determination of the major isosteroidal alkaloids in bulbs of Fritillaria by high-performance liquid chromatography coupled with evaporative light scattering detection</article-title><source>J. Chromatogr. A</source><year>2001</year><volume>909</volume><fpage>207</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1016/S0021-9673(00)01083-9</pub-id><pub-id pub-id-type="pmid">11269520</pub-id></element-citation></ref><ref id="B37-ijms-20-01667"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.-L.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Lin</surname><given-names>G.</given-names></name><name><surname>Chan</surname><given-names>S.-W.</given-names></name><name><surname>Ho</surname><given-names>Y.-P.</given-names></name></person-group><article-title>Simultaneous determination of seven major isosteroidal alkaloids in bulbs of Fritillaria by gas chromatography</article-title><source>J. Chromatogr. A</source><year>2000</year><volume>873</volume><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/S0021-9673(00)00049-2</pub-id><pub-id pub-id-type="pmid">10757299</pub-id></element-citation></ref><ref id="B38-ijms-20-01667"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Bi</surname><given-names>K.</given-names></name><name><surname>Qian</surname><given-names>Y.</given-names></name><name><surname>Ning</surname><given-names>L.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name></person-group><article-title>A pre-column derivatization HPLC method for the determination of peimine and peiminine in Bulbus Fritillariae</article-title><source>J. Chin. Pharm. Sci.</source><year>1996</year><volume>5</volume><fpage>213</fpage><lpage>218</lpage></element-citation></ref><ref id="B39-ijms-20-01667"><label>39.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Shi</surname><given-names>R.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name></person-group><article-title>Study on the contents mensuration of total alkaloid in Bulbus Fritillariae by acid dye colorinetry</article-title><source>Proceedings of the Fifth National Academic Conference on the Identification of Traditional Chinese Medicine</source><conf-loc>Weihai, China</conf-loc><conf-date>1 August 2001</conf-date><fpage>152</fpage><lpage>155</lpage></element-citation></ref><ref id="B40-ijms-20-01667"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Xiang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Study on the principal component analysis method to determination of trace elements of Fritillaria thunbergii Miq</article-title><source>Guangdong Trace Elem. Sci.</source><year>2008</year><volume>15</volume><fpage>31</fpage><lpage>35</lpage></element-citation></ref><ref id="B41-ijms-20-01667"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>You</surname><given-names>W.</given-names></name><name><surname>Zheng</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Jia</surname><given-names>Z.</given-names></name></person-group><article-title>Determination of peimine and peiminine in Bulbus Fritillariae Thunbergii by capillary electrophoresis by indirect UV detection using <italic>N</italic>-(1-naphthyl)ethylenediamine dihydrochloride as probe</article-title><source>Electrophoresis</source><year>2012</year><volume>33</volume><fpage>2152</fpage><lpage>2158</lpage><pub-id pub-id-type="doi">10.1002/elps.201200021</pub-id><?supplied-pmid 22821492?><pub-id pub-id-type="pmid">22821492</pub-id></element-citation></ref><ref id="B42-ijms-20-01667"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>Z.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Acworth</surname><given-names>I.N.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Liang</surname><given-names>L.</given-names></name></person-group><article-title>A non-derivative method for the quantitative analysis of isosteroidal alkaloids from Fritillaria by high performance liquid chromatography combined with charged aerosol detection</article-title><source>Talanta</source><year>2016</year><volume>151</volume><fpage>239</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.talanta.2016.01.027</pub-id><?supplied-pmid 26946033?><pub-id pub-id-type="pmid">26946033</pub-id></element-citation></ref><ref id="B43-ijms-20-01667"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lou</surname><given-names>Y.</given-names></name><name><surname>Cai</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Tu</surname><given-names>S.</given-names></name><name><surname>Pei</surname><given-names>K.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Qin</surname><given-names>K.</given-names></name><name><surname>Cai</surname><given-names>B.</given-names></name></person-group><article-title>Element analysis and characteristic identification of non-fumigated and sulfur-fumigated Fritillaria thunbergii Miq. using microwave digestion-inductively coupled plasma atomic emission spectrometry combined with Fourier transform infrared spectrometry</article-title><source>Pharmacogn. Mag.</source><year>2014</year><volume>10</volume><fpage>S30</fpage><lpage>S36</lpage><pub-id pub-id-type="doi">10.4103/0973-1296.127337</pub-id><pub-id pub-id-type="pmid">24914306</pub-id></element-citation></ref><ref id="B44-ijms-20-01667"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>W.</given-names></name><name><surname>Rong</surname><given-names>J.</given-names></name><name><surname>Sheng</surname><given-names>Z.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name></person-group><article-title>Study on HPLC specific chromatogram of Fritillaric thunbergii</article-title><source>Chin. J. Hosp. Pharm.</source><year>2008</year><volume>28</volume><fpage>1458</fpage><lpage>1460</lpage></element-citation></ref><ref id="B45-ijms-20-01667"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Wen</surname><given-names>Q.</given-names></name><name><surname>Tong</surname><given-names>X.</given-names></name><name><surname>Fan</surname><given-names>B.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name></person-group><article-title>Study on serum pharmacochemistry of Fritillaria thunbergii Miq. by LC-MS in rats</article-title><source>Chin. J. Pharmacovigil.</source><year>2014</year><volume>11</volume><fpage>714</fpage><lpage>720</lpage></element-citation></ref><ref id="B46-ijms-20-01667"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morimoto</surname><given-names>H.</given-names></name><name><surname>Kimata</surname><given-names>S.</given-names></name></person-group><article-title>Studies on the components of Fritillaria Thunbergii Miq. I. isolation of peimine and its new glycoside</article-title><source>Chem. Pharm. Bull.</source><year>1960</year><volume>8</volume><fpage>302</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1248/cpb.8.302</pub-id></element-citation></ref><ref id="B47-ijms-20-01667"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>M.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Deng</surname><given-names>G.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name></person-group><article-title>Comparison of in vitro dissolution rates of three constituents in superfine powder, coarse powder and decoction pieces of Fritillaria thunbergii</article-title><source>Chin. Tradit. Patent Med.</source><year>2017</year><volume>39</volume><fpage>1232</fpage><lpage>1235</lpage></element-citation></ref><ref id="B48-ijms-20-01667"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Que</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>Z.</given-names></name></person-group><article-title>Determination and comparision of alkaloids in Dongbeimu, Zhebeimu and Chuanbeimu by thin layer chromatography</article-title><source>Zhejiang Pharm.</source><year>1984</year><volume>1</volume><fpage>18</fpage><lpage>20</lpage></element-citation></ref><ref id="B49-ijms-20-01667"><label>49.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>X.</given-names></name></person-group><article-title>Reversing Multi-Drug Resistance on Tumor Cells and Pharmacokinetics Study on Ingredients in a Traditional Chinese Medicine Fritillaria thunbergii Miq</article-title><source>Master&#x02019;s Thesis</source><publisher-name>Yunnan University of Traditional Chinese Medicine</publisher-name><publisher-loc>Kunming, China</publisher-loc><year>2016</year></element-citation></ref><ref id="B50-ijms-20-01667"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>A.</given-names></name><name><surname>Hu</surname><given-names>M.</given-names></name></person-group><article-title>Cotents mensuration of total alkaloid in Bulbus Fritillariae by acid dye two-phase titration</article-title><source>Chin. J. Mod. Appl. Pharm.</source><year>1998</year><volume>15</volume><fpage>50</fpage><lpage>51</lpage></element-citation></ref><ref id="B51-ijms-20-01667"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name></person-group><article-title>Determination of the proportion of peimine in Thunbery Fritillary Bulb</article-title><source>Heilongjiang Sci. Technol. Inf.</source><year>2011</year><fpage>34</fpage><pub-id pub-id-type="doi">10.3969/j.issn.1673-1328.2011.33.051</pub-id></element-citation></ref><ref id="B52-ijms-20-01667"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>K.</given-names></name><name><surname>Du</surname><given-names>L.</given-names></name></person-group><article-title>Determination of the proportion of Cu, Fe, Zn, and Ca elements in Thunbery Fritillary Bulb and Tendrilleaf Fritillary Bulb</article-title><source>Sichuang Food Ferment.</source><year>2007</year><volume>43</volume><fpage>65</fpage><lpage>67</lpage></element-citation></ref><ref id="B53-ijms-20-01667"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name></person-group><article-title>The measurement and analysis of eight elements in several sorts of Fritillaria of traditional Chinese medicine</article-title><source>Stud. Trace Elem. Health</source><year>2004</year><volume>21</volume><fpage>30</fpage><lpage>33</lpage></element-citation></ref><ref id="B54-ijms-20-01667"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Shen</surname><given-names>P.</given-names></name></person-group><article-title>Determination of selenium with different valences in Zhebeimu by spectrophotometry</article-title><source>Guangdong Trace Elem. Sci.</source><year>1998</year><volume>5</volume><fpage>66</fpage><lpage>68</lpage></element-citation></ref><ref id="B55-ijms-20-01667"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Zou</surname><given-names>Y.</given-names></name><name><surname>Zhan</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Lu</surname><given-names>G.</given-names></name><name><surname>Lai</surname><given-names>F.</given-names></name></person-group><article-title>Survey of heavy metal pollution in four chinese crude drugs and their cultivated soils</article-title><source>Bull. Environ. Contam. Toxicol.</source><year>2008</year><volume>81</volume><fpage>571</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1007/s00128-007-9170-2</pub-id><?supplied-pmid 18839045?><pub-id pub-id-type="pmid">18839045</pub-id></element-citation></ref><ref id="B56-ijms-20-01667"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Chan</surname><given-names>S.W.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Shaw</surname><given-names>P.C.</given-names></name><name><surname>Lin</surname><given-names>G.</given-names></name></person-group><article-title>Investigation of association of chemical profiles with the tracheobronchial relaxant activity of Chinese medicinal herb Beimu derived from various Fritillaria species</article-title><source>J. Ethnopharmacol.</source><year>2018</year><volume>210</volume><fpage>39</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2017.08.027</pub-id><pub-id pub-id-type="pmid">28842340</pub-id></element-citation></ref><ref id="B57-ijms-20-01667"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name></person-group><article-title>Comparative analysis of the effective components (alkaloids) of Fritillaria anhuiensis S.C.Chen et S.P.Yin, Fritillariae Thunbergii Bulbus and Fritillariae Cirrhosae Bulbus</article-title><source>Chin. Tradit. Herbal Drugs</source><year>1993</year><volume>24</volume><fpage>351</fpage><lpage>353</lpage></element-citation></ref><ref id="B58-ijms-20-01667"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Zheng</surname><given-names>S.</given-names></name></person-group><article-title>Grey relational analysis and determination of elements in Fritillaria Thunbergii Bulb and Fritillariae Cirrhosae Bulb</article-title><source>J. Chin. Med. Mater.</source><year>1997</year><volume>20</volume><fpage>291</fpage><lpage>293</lpage></element-citation></ref><ref id="B59-ijms-20-01667"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>Sensitive UHPLC-MS/MS quantitation and pharmacokinetic comparisons of multiple alkaloids from Fuzi-Beimu and single herb aqueous extracts following oral delivery in rats</article-title><source>J. Chromatogr. B</source><year>2017</year><volume>1058</volume><fpage>24</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.jchromb.2017.05.016</pub-id><?supplied-pmid 28528229?><pub-id pub-id-type="pmid">28528229</pub-id></element-citation></ref><ref id="B60-ijms-20-01667"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Y.</given-names></name><name><surname>Gu</surname><given-names>H.</given-names></name></person-group><article-title>Determination of peimine and peiminine in Fritillaria thunbergii by HPLC-ELSD</article-title><source>Acta Pharm. Sin.</source><year>2005</year><volume>40</volume><fpage>550</fpage><lpage>552</lpage></element-citation></ref><ref id="B61-ijms-20-01667"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>R.</given-names></name><name><surname>Cheng</surname><given-names>Z.</given-names></name><name><surname>Gong</surname><given-names>X.</given-names></name></person-group><article-title>Determination and comparison of trace elements in four sort of Bulbus Fritillariae by microwave digestion-atomic absorption spectrometry</article-title><source>Spectrosc. Spectr. Anal.</source><year>2007</year><volume>27</volume><fpage>2591</fpage><lpage>2594</lpage></element-citation></ref><ref id="B62-ijms-20-01667"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>X.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Luan</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>Establishment of element fingerprint and multielement analysis of Fritillaria thunbergii by inductively coupled plasma optical emission spectrometry</article-title><source>Biol. Trace Elem. Res.</source><year>2010</year><volume>135</volume><fpage>304</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1007/s12011-010-8627-z</pub-id><?supplied-pmid 20174977?><pub-id pub-id-type="pmid">20174977</pub-id></element-citation></ref><ref id="B63-ijms-20-01667"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Yi</surname><given-names>W.</given-names></name></person-group><article-title>Study on the determination of peimine in Fritillaria thunbergii Miq from different sources by using HPLC-ELSD</article-title><source>J. Jaingxi Univ. Tradit. Chin. Med.</source><year>2009</year><volume>21</volume><fpage>51</fpage><lpage>52</lpage></element-citation></ref><ref id="B64-ijms-20-01667"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Su</surname><given-names>J.H.</given-names></name><name><surname>Zhang</surname><given-names>H.F.</given-names></name><name><surname>Gu</surname><given-names>B.R.</given-names></name><name><surname>Xing</surname><given-names>Y.W.</given-names></name><name><surname>Xue</surname><given-names>M.</given-names></name></person-group><article-title>Multiple analytical methods for identification and quality evaluation of Fritillariae Thunbergii Bulbus based on biological single molecules by high-performance liquid chromatography</article-title><source>J. Sep. Sci.</source><year>2016</year><volume>39</volume><fpage>3536</fpage><lpage>3543</lpage><pub-id pub-id-type="doi">10.1002/jssc.201600356</pub-id><pub-id pub-id-type="pmid">27452292</pub-id></element-citation></ref><ref id="B65-ijms-20-01667"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Lao</surname><given-names>A.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>G.</given-names></name><name><surname>Xu</surname><given-names>R.</given-names></name></person-group><article-title>Studies on chemical constituents of Fritillaria thunbergii Miq. III. isolation and identification of Zhebeinone</article-title><source>Acta Pharm. Sin.</source><year>1992</year><volume>27</volume><fpage>472</fpage><lpage>475</lpage></element-citation></ref><ref id="B66-ijms-20-01667"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Lao</surname><given-names>A.</given-names></name><name><surname>Ma</surname><given-names>G.</given-names></name><name><surname>Xu</surname><given-names>R.</given-names></name></person-group><article-title>Studies on chemical constituents of Fritillaria thunbergii Miq. II</article-title><source>Acta Pharm. Sin.</source><year>1991</year><volume>33</volume><fpage>923</fpage><lpage>926</lpage></element-citation></ref><ref id="B67-ijms-20-01667"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Lao</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>R.</given-names></name></person-group><article-title>Studies on chemical constituents of Fritillaria thunbergii Miq. IV</article-title><source>Chin. Bull. Bot.</source><year>1993</year><volume>35</volume><fpage>238</fpage><lpage>241</lpage></element-citation></ref><ref id="B68-ijms-20-01667"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Lao</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>R.</given-names></name></person-group><article-title>Studies on the chemical constituents of fresh bulbs of Fritillaria thunbergii Miq</article-title><source>China J. Chin. Mater. Med.</source><year>1993</year><volume>18</volume><fpage>354</fpage><lpage>355</lpage></element-citation></ref><ref id="B69-ijms-20-01667"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>G.</given-names></name><name><surname>Lao</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>R.</given-names></name></person-group><article-title>Studies on chemical constituents of Fritillaria thunbergii Miq</article-title><source>Acta Pharm. Sin.</source><year>1991</year><volume>26</volume><fpage>231</fpage><lpage>233</lpage></element-citation></ref><ref id="B70-ijms-20-01667"><label>70.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name></person-group><article-title>Study on the Determination of Alkaloid and Nucleosides in Various Species of Fritillaria</article-title><source>Master&#x02019;s Thesis</source><publisher-name>Hunan Normal University</publisher-name><publisher-loc>Changsha, China</publisher-loc><year>2008</year></element-citation></ref><ref id="B71-ijms-20-01667"><label>71.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name></person-group><article-title>HPLC quantitative analysis of uracil and three nucleotides in Bulbus Fritillariae and the application for variety discrimination</article-title><source>Proceedings of the Chinese Chemical Society: The 16th National Conference on Organic Analysis and Bioanalysis Proceeding</source><conf-loc>Neimenggu, China</conf-loc><conf-date>12 August 2011</conf-date><fpage>8</fpage></element-citation></ref><ref id="B72-ijms-20-01667"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J.L.</given-names></name><name><surname>Xin</surname><given-names>G.Z.</given-names></name><name><surname>Shi</surname><given-names>Z.Q.</given-names></name><name><surname>Ren</surname><given-names>M.T.</given-names></name><name><surname>Qi</surname><given-names>L.W.</given-names></name><name><surname>Li</surname><given-names>H.J.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group><article-title>Characterization and identification of steroidal alkaloids in Fritillaria species using liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry</article-title><source>J. Chromatogr. A</source><year>2010</year><volume>1217</volume><fpage>7109</fpage><lpage>7122</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2010.09.019</pub-id><pub-id pub-id-type="pmid">20926090</pub-id></element-citation></ref><ref id="B73-ijms-20-01667"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Ding</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Tong</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Comparison and evaluation of antimuscarinic and anti-inflammatory effects of five Bulbus fritillariae species based on UPLC-Q/TOF integrated dual-luciferase reporter assay, PCA and ANN analysis</article-title><source>J. Chromatogr. B</source><year>2017</year><volume>1041&#x02013;1042</volume><fpage>60</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.jchromb.2016.12.012</pub-id></element-citation></ref><ref id="B74-ijms-20-01667"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name></person-group><article-title>Bioaccessibility and safety assessment of trace elements from decoction of &#x0201c;Zhebawei&#x0201d; herbal medicines by in vitro digestion method</article-title><source>J. Trace Elem. Med. Biol.</source><year>2014</year><volume>28</volume><fpage>173</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.jtemb.2013.12.007</pub-id><?supplied-pmid 24472669?><pub-id pub-id-type="pmid">24472669</pub-id></element-citation></ref><ref id="B75-ijms-20-01667"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Ji</surname><given-names>H.</given-names></name><name><surname>Lin</surname><given-names>B.Q.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group><article-title>The effects of five alkaloids from Bulbus Fritillariae on the concentration of cAMP in HEK cells transfected with muscarinic M<sub>2</sub> receptor plasmid</article-title><source>Am. J. Chin. Med.</source><year>2006</year><volume>34</volume><fpage>901</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1142/S0192415X06004375</pub-id><?supplied-pmid 17080553?><pub-id pub-id-type="pmid">17080553</pub-id></element-citation></ref><ref id="B76-ijms-20-01667"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name></person-group><article-title>Comparative pharmacokinetic studies of peimine and peiminine in rat plasma by LC-MS-MS after oral administration of Fritillaria thunbergii Miq. and Fritillaria thunbergii Miq.&#x02014;Glycyrrhiza uralensis Fisch. couple extract</article-title><source>Pharmazie</source><year>2011</year><volume>66</volume><fpage>684</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1691/ph.2011.1022</pub-id><pub-id pub-id-type="pmid">22026124</pub-id></element-citation></ref><ref id="B77-ijms-20-01667"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.-H.</given-names></name><name><surname>Zhang</surname><given-names>H.-M.</given-names></name><name><surname>Guan</surname><given-names>Z.-Y.</given-names></name><name><surname>Zhu</surname><given-names>W.-F.</given-names></name><name><surname>Yi</surname><given-names>W.-J.</given-names></name><name><surname>Guan</surname><given-names>Y.-M.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>H.-N.</given-names></name></person-group><article-title>Sex dependent pharmacokinetics, tissue distribution and excretion of peimine and peiminine in rats assessed by liquid chromatography&#x02013;tandem mass spectrometry</article-title><source>J. Ethnopharmacol.</source><year>2013</year><volume>145</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.09.054</pub-id><?supplied-pmid 23123795?><pub-id pub-id-type="pmid">23123795</pub-id></element-citation></ref><ref id="B78-ijms-20-01667"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Effects of some drugs for resolving phlegm on blood rehological property in rats</article-title><source>J. Tradit. Chin. Med.</source><year>2002</year><volume>3</volume><fpage>38</fpage></element-citation></ref><ref id="B79-ijms-20-01667"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Ally</surname><given-names>M.S.</given-names></name><name><surname>Hou</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>A novel method for evaluating the cardiotoxicity of traditional Chinese medicine compatibility by using support vector machine model combined with metabonomics</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2016</year><volume>2016</volume><fpage>e6012761</fpage><pub-id pub-id-type="doi">10.1155/2016/6012761</pub-id></element-citation></ref><ref id="B80-ijms-20-01667"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>An</surname><given-names>C.</given-names></name><name><surname>Hu</surname><given-names>K.</given-names></name><name><surname>Zhou</surname><given-names>K.</given-names></name><name><surname>Duan</surname><given-names>H.</given-names></name><name><surname>Tang</surname><given-names>M.</given-names></name></person-group><article-title>Multidrug resistance reversal activity of total alkaloid from Fritillaria thunbergii on cisplatin-resistant human lung adenocarcinoma A549/DDP cells</article-title><source>Chin. J. Pharmacol. Toxicol.</source><year>2013</year><volume>27</volume><fpage>315</fpage><lpage>320</lpage></element-citation></ref><ref id="B81-ijms-20-01667"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Qiao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>An</surname><given-names>C.</given-names></name><name><surname>Hu</surname><given-names>K.</given-names></name><name><surname>Tang</surname><given-names>M.</given-names></name></person-group><article-title>Acute and sub-chronic toxicity studies of the extract of Thunberg Fritillary Bulb</article-title><source>Regul. Toxicol. Pharmacol.</source><year>2014</year><volume>68</volume><fpage>370</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/j.yrtph.2014.01.007</pub-id><pub-id pub-id-type="pmid">24486111</pub-id></element-citation></ref><ref id="B82-ijms-20-01667"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name></person-group><article-title>Protection effect of Fritillaria thunbergii aginst hyperthyroidism in rats and mice</article-title><source>China Pharm.</source><year>2010</year><volume>21</volume><fpage>1362</fpage><lpage>1363</lpage></element-citation></ref><ref id="B83-ijms-20-01667"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Peng</surname><given-names>X.</given-names></name></person-group><article-title>Experimental study on percutaneous absorption of main alkaloids in Fritillaira Thunbergii in vitro</article-title><source>Asia-Pac. Tradit. Med.</source><year>2011</year><volume>7</volume><fpage>15</fpage><lpage>18</lpage></element-citation></ref><ref id="B84-ijms-20-01667"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>W.</given-names></name></person-group><article-title>Antioxidant activity of polysaccharide from Fritillaria thunbergii Bulbus in vitro</article-title><source>Chin. Arch. Tradit. Chin. Med.</source><year>2014</year><volume>32</volume><fpage>1191</fpage><lpage>1193</lpage></element-citation></ref><ref id="B85-ijms-20-01667"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Cui</surname><given-names>W.-X.</given-names></name><name><surname>Zhang</surname><given-names>M.-X.</given-names></name><name><surname>Li</surname><given-names>Z.-H.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name></person-group><article-title>Optimization of supercritical fluid extraction of total alkaloids, peimisine, peimine and peiminine from the Bulb of Fritillaria thunbergii Miq, and evaluation of antioxidant activities of the extracts</article-title><source>Materials</source><year>2016</year><volume>9</volume><elocation-id>524</elocation-id><pub-id pub-id-type="doi">10.3390/ma9070524</pub-id></element-citation></ref><ref id="B86-ijms-20-01667"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Han</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name></person-group><article-title>Pharmacodynamic compariason on anti-tussive and expectorant effects between Fritillaria anhuiensis S.C.Chen et S.P.Yin, Fritillariae Cirrhosae Bulbus and Fritillariae Thunbergii Bulbus</article-title><source>Anhui Med. J.</source><year>1993</year><volume>14</volume><fpage>57</fpage><lpage>58</lpage></element-citation></ref><ref id="B87-ijms-20-01667"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Wei</surname><given-names>B.</given-names></name></person-group><article-title>The effect of Zhejiang Fritillaria Thunbergii against immunological CP/CPPS</article-title><source>Chin. Arch. Tradit. Chin. Med.</source><year>2011</year><volume>28</volume><fpage>1023</fpage><lpage>1025</lpage></element-citation></ref><ref id="B88-ijms-20-01667"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Pan</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Lu</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title>Peimine, a main active ingredient of Fritillaria, exhibits anti-inflammatory and pain suppression properties at the cellular level</article-title><source>Fitoterapia</source><year>2016</year><volume>111</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2016.03.018</pub-id><?supplied-pmid 27033404?><pub-id pub-id-type="pmid">27033404</pub-id></element-citation></ref><ref id="B89-ijms-20-01667"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>X.</given-names></name><name><surname>Tong</surname><given-names>Z.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name></person-group><article-title>Pharmacodynamic compariason of Fritillaria unibracteata, Fritillaria unibracteata var. wabensis and Fritillaria thunbergii cultivated</article-title><source>Chin. J. Exp. Tradit. Med. Formulae</source><year>2012</year><volume>18</volume><fpage>244</fpage><lpage>248</lpage></element-citation></ref><ref id="B90-ijms-20-01667"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Tang</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Yan</surname><given-names>X.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name></person-group><article-title>Comparative studies on antiussive effect between Fritillaria unibracteata Hisao et K. C. Hisa and Fritillaria thunbergii Miq with chemical stimulation induced cough method</article-title><source>Lishizhen Med. Mater. Med. Res.</source><year>2012</year><volume>23</volume><fpage>2522</fpage><lpage>2525</lpage></element-citation></ref><ref id="B91-ijms-20-01667"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Nie</surname><given-names>S.</given-names></name><name><surname>Weng</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name></person-group><article-title>Experiment studies on anti-tumor effect in vivo and in vitro of Aconitum carmichaelii Debx. and Fritillaria thunbergii Miq. used singly or matched</article-title><source>Chin. J. Exp. Tradit. Med. Formulae</source><year>2005</year><volume>11</volume><fpage>25</fpage><lpage>28</lpage></element-citation></ref><ref id="B92-ijms-20-01667"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>Study on the anti-ulcer and analgesia effects of Fritillaria thunbergii Miq</article-title><source>Northwest Pharm. J.</source><year>1998</year><volume>13</volume><fpage>208</fpage><lpage>209</lpage></element-citation></ref><ref id="B93-ijms-20-01667"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>D.</given-names></name></person-group><article-title>Study on the anti-inflammatory and anti-diarrhea effects of Fritillaria thunbergii Miq</article-title><source>Hunan Guiding J. Tradit. Chin. Med. Pharmacol.</source><year>1998</year><volume>4</volume><fpage>30</fpage><lpage>31</lpage></element-citation></ref><ref id="B94-ijms-20-01667"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name></person-group><article-title>Effect of extracts from Fritillaria thunbergii on oral ulcer model in rats</article-title><source>Mod. Pract. Med.</source><year>2018</year><volume>30</volume><fpage>242</fpage><lpage>243</lpage></element-citation></ref><ref id="B95-ijms-20-01667"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jian</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name></person-group><article-title>Anti-cancer activities of diterpenoids derived from euphorbia fischeriana steud</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>23020387</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23020387</pub-id></element-citation></ref><ref id="B96-ijms-20-01667"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohr</surname><given-names>M.</given-names></name><name><surname>Oleinikov</surname><given-names>K.</given-names></name><name><surname>Jung</surname><given-names>M.</given-names></name><name><surname>Sandjo</surname><given-names>L.P.</given-names></name><name><surname>Opatz</surname><given-names>T.</given-names></name><name><surname>Erkel</surname><given-names>G.</given-names></name></person-group><article-title>Anti-inflammatory tetraquinane diterpenoids from a Crinipellis species</article-title><source>Bioorg. Med. Chem.</source><year>2017</year><volume>25</volume><fpage>514</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2016.11.016</pub-id><pub-id pub-id-type="pmid">27887964</pub-id></element-citation></ref><ref id="B97-ijms-20-01667"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolak</surname><given-names>U.</given-names></name><name><surname>Kabouche</surname><given-names>A.</given-names></name><name><surname>Ozturk</surname><given-names>M.</given-names></name><name><surname>Kabouche</surname><given-names>Z.</given-names></name><name><surname>Topcu</surname><given-names>G.</given-names></name><name><surname>Ulubelen</surname><given-names>A.</given-names></name></person-group><article-title>Antioxidant diterpenoids from the roots of Salvia barrelieri</article-title><source>Phytochem. Anal.</source><year>2009</year><volume>20</volume><fpage>320</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1002/pca.1130</pub-id><pub-id pub-id-type="pmid">19402189</pub-id></element-citation></ref><ref id="B98-ijms-20-01667"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hattori</surname><given-names>H.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name><name><surname>Fukushima</surname><given-names>M.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Matsuda</surname><given-names>A.</given-names></name></person-group><article-title>Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity</article-title><source>J. Med. Chem.</source><year>1996</year><volume>39</volume><fpage>5005</fpage><lpage>5011</lpage><pub-id pub-id-type="doi">10.1021/jm960537g</pub-id><?supplied-pmid 8960561?><pub-id pub-id-type="pmid">8960561</pub-id></element-citation></ref><ref id="B99-ijms-20-01667"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichikawa</surname><given-names>S.</given-names></name><name><surname>Yamaguchi</surname><given-names>M.</given-names></name><name><surname>Matsuda</surname><given-names>A.</given-names></name></person-group><article-title>Antibacterial nucleoside natural products inhibiting phospho-murNAc-pentapeptide translocase: Chemistry and structure-activity relationship</article-title><source>Curr. Med. Chem.</source><year>2015</year><volume>22</volume><fpage>3951</fpage><lpage>3979</lpage><pub-id pub-id-type="doi">10.2174/0929867322666150818103502</pub-id><?supplied-pmid 26282943?><pub-id pub-id-type="pmid">26282943</pub-id></element-citation></ref><ref id="B100-ijms-20-01667"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichikawa</surname><given-names>S.</given-names></name><name><surname>Matsuda</surname><given-names>A.</given-names></name></person-group><article-title>Nucleoside natural products and related analogs with potential therapeutic properties as antibacterial and antiviral agents</article-title><source>Expert Opin. Ther. Pat.</source><year>2007</year><volume>17</volume><fpage>487</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1517/13543776.17.5.487</pub-id></element-citation></ref><ref id="B101-ijms-20-01667"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jan</surname><given-names>A.T.</given-names></name><name><surname>Azam</surname><given-names>M.</given-names></name><name><surname>Siddiqui</surname><given-names>K.</given-names></name><name><surname>Ali</surname><given-names>A.</given-names></name><name><surname>Choi</surname><given-names>I.</given-names></name><name><surname>Haq</surname><given-names>Q.M.</given-names></name></person-group><article-title>Heavy metals and human health: Mechanistic insight into toxicity and counter defense system of antioxidants</article-title><source>Int. J. Mol. Sci.</source><year>2015</year><volume>16</volume><fpage>29592</fpage><lpage>29630</lpage><pub-id pub-id-type="doi">10.3390/ijms161226183</pub-id><pub-id pub-id-type="pmid">26690422</pub-id></element-citation></ref><ref id="B102-ijms-20-01667"><label>102.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>Cancer</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/cancer/en/">https://www.who.int/cancer/en/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-01-22">(accessed on 22 January 2019)</date-in-citation></element-citation></ref><ref id="B103-ijms-20-01667"><label>103.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>National Cancer Institute</collab></person-group><article-title>Side Effects of Cancer Treatment</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.cancer.gov/about-cancer/treatment/side-effects">https://www.cancer.gov/about-cancer/treatment/side-effects</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-01-22">(accessed on 22 January 2019)</date-in-citation></element-citation></ref><ref id="B104-ijms-20-01667"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>H.</given-names></name><name><surname>Mu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>J.P.</given-names></name></person-group><article-title>A Systematic Review of Randomized Controlled Trials on Oral Chinese Herbal Medicine for Prostate Cancer</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0160253</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0160253</pub-id><pub-id pub-id-type="pmid">27490098</pub-id></element-citation></ref><ref id="B105-ijms-20-01667"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Peng</surname><given-names>Z.</given-names></name><name><surname>Su</surname><given-names>C.</given-names></name></person-group><article-title>Potential anti-cancer activities and mechanisms of costunolide and dehydrocostuslactone</article-title><source>Int. J. Mol. Sci.</source><year>2015</year><volume>16</volume><fpage>10888</fpage><lpage>10906</lpage><pub-id pub-id-type="doi">10.3390/ijms160510888</pub-id><pub-id pub-id-type="pmid">25984608</pub-id></element-citation></ref><ref id="B106-ijms-20-01667"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neubig</surname><given-names>R.R.</given-names></name><name><surname>Spedding</surname><given-names>M.</given-names></name><name><surname>Kenakin</surname><given-names>T.</given-names></name><name><surname>Christopoulos</surname><given-names>A.</given-names></name></person-group><article-title>International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology</article-title><source>Pharmacol. Rev.</source><year>2003</year><volume>55</volume><fpage>597</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1124/pr.55.4.4</pub-id><pub-id pub-id-type="pmid">14657418</pub-id></element-citation></ref><ref id="B107-ijms-20-01667"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>G.C.</given-names></name><name><surname>Blake</surname><given-names>J.T.</given-names></name><name><surname>Talento</surname><given-names>A.</given-names></name><name><surname>Nguyen</surname><given-names>M.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>Sirotina</surname><given-names>A.</given-names></name><name><surname>Shah</surname><given-names>K.</given-names></name><name><surname>Mulvany</surname><given-names>K.</given-names></name><name><surname>Hora</surname><given-names>D.</given-names><suffix>Jr.</suffix></name><name><surname>Cunningham</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo</article-title><source>J. Immunol.</source><year>1997</year><volume>158</volume><fpage>5120</fpage><lpage>5128</lpage><?supplied-pmid 9164927?><pub-id pub-id-type="pmid">9164927</pub-id></element-citation></ref><ref id="B108-ijms-20-01667"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>W.H.</given-names></name><name><surname>Han</surname><given-names>S.</given-names></name><name><surname>Peng</surname><given-names>B.W.</given-names></name><name><surname>Yin</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Y.L.</given-names></name><name><surname>He</surname><given-names>X.H.</given-names></name><name><surname>Li</surname><given-names>W.X.</given-names></name></person-group><article-title>Selective inhibition of CCR7(-) effector memory T cell activation by a novel peptide targeting Kv1.3 channel in a rat experimental autoimmune encephalomyelitis model</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>29479</fpage><lpage>29494</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.379594</pub-id><pub-id pub-id-type="pmid">22761436</pub-id></element-citation></ref><ref id="B109-ijms-20-01667"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>W.A.</given-names></name><name><surname>Goldin</surname><given-names>A.L.</given-names></name><name><surname>Waxman</surname><given-names>S.G.</given-names></name></person-group><article-title>International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels</article-title><source>Pharmacol. Rev.</source><year>2005</year><volume>57</volume><fpage>397</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1124/pr.57.4.4</pub-id><pub-id pub-id-type="pmid">16382098</pub-id></element-citation></ref><ref id="B110-ijms-20-01667"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raymond</surname><given-names>C.K.</given-names></name><name><surname>Castle</surname><given-names>J.</given-names></name><name><surname>Garrett-Engele</surname><given-names>P.</given-names></name><name><surname>Armour</surname><given-names>C.D.</given-names></name><name><surname>Kan</surname><given-names>Z.</given-names></name><name><surname>Tsinoremas</surname><given-names>N.</given-names></name><name><surname>Johnson</surname><given-names>J.M.</given-names></name></person-group><article-title>Expression of alternatively spliced sodium channel alpha-subunit genes. Unique splicing patterns are observed in dorsal root ganglia</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>46234</fpage><lpage>46241</lpage><pub-id pub-id-type="doi">10.1074/jbc.M406387200</pub-id><?supplied-pmid 15302875?><pub-id pub-id-type="pmid">15302875</pub-id></element-citation></ref><ref id="B111-ijms-20-01667"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rush</surname><given-names>A.M.</given-names></name><name><surname>Dib-Hajj</surname><given-names>S.D.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Cummins</surname><given-names>T.R.</given-names></name><name><surname>Black</surname><given-names>J.A.</given-names></name><name><surname>Waxman</surname><given-names>S.G.</given-names></name></person-group><article-title>A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2006</year><volume>103</volume><fpage>8245</fpage><lpage>8250</lpage><pub-id pub-id-type="doi">10.1073/pnas.0602813103</pub-id><pub-id pub-id-type="pmid">16702558</pub-id></element-citation></ref><ref id="B112-ijms-20-01667"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>J.J.</given-names></name><name><surname>Reimann</surname><given-names>F.</given-names></name><name><surname>Nicholas</surname><given-names>A.K.</given-names></name><name><surname>Thornton</surname><given-names>G.</given-names></name><name><surname>Roberts</surname><given-names>E.</given-names></name><name><surname>Springell</surname><given-names>K.</given-names></name><name><surname>Karbani</surname><given-names>G.</given-names></name><name><surname>Jafri</surname><given-names>H.</given-names></name><name><surname>Mannan</surname><given-names>J.</given-names></name><name><surname>Raashid</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>An SCN9A channelopathy causes congenital inability to experience pain</article-title><source>Nature</source><year>2006</year><volume>444</volume><fpage>894</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1038/nature05413</pub-id><?supplied-pmid 17167479?><pub-id pub-id-type="pmid">17167479</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="ijms-20-01667-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flowchart of the selection process of Fritillariae Thunbergii Bulbus studies.</p></caption><graphic xlink:href="ijms-20-01667-g001"/></fig><fig id="ijms-20-01667-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Molecular structures of the 14 chemical constituents of Fritillariae Thunbergii Bulbus. Note: A4: Zhebeinone; A11: Zhebeininoside; A16: Eduardine; A17: Zhebeirine; A21: Zhebeinone-3-&#x003b2;-<sc>d</sc>-glucoside; A23: Frithunbol A; A24: Frithunbol B; A25: Eduardinine; A26: 3&#x003b2;-hydroxy-5&#x003b1;-jervanin-12-en-6-one; C2: Isopimaran-19-oic acid, methyl ester; C3: Ent-kauran-16&#x003b2;, 17-diol; C4: Ent-kauran-16&#x003b1;, 17-diol; C9: Trans-comminic acid, methyl ester; C12: Ent-16&#x003b2;-hydroxy-kauran-17-yl ent-kaur-15-en-17-oate.</p></caption><graphic xlink:href="ijms-20-01667-g002"/></fig><fig id="ijms-20-01667-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Multiple pharmacological effects of Fritillariae Thunbergii Bulbus.</p></caption><graphic xlink:href="ijms-20-01667-g003"/></fig><table-wrap id="ijms-20-01667-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-20-01667-t001_Table 1</object-id><label>Table 1</label><caption><p>Summary of the 134 chemical constituents isolated from Fritillariae Thunbergii Bulbus.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">No.</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Derivatives and Constitutions</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Molecular Formula</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">PubChem CID/SID</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Molecule Weight (g/mol)</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Method</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SRV Group</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SNRV Group</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>A</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Alkaloids (<italic>n</italic> = 26)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A1</td><td align="center" valign="middle" rowspan="1" colspan="1">Peimine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>45</sub>NO<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">131900</td><td align="center" valign="middle" rowspan="1" colspan="1">431.661</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>]; HPLC-ELSD [<xref rid="B44-ijms-20-01667" ref-type="bibr">44</xref>,<xref rid="B60-ijms-20-01667" ref-type="bibr">60</xref>,<xref rid="B63-ijms-20-01667" ref-type="bibr">63</xref>]; HPLC-ESI/MS [<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>]; HPLC-MS [<xref rid="B21-ijms-20-01667" ref-type="bibr">21</xref>]; UPLC-ELSD [<xref rid="B26-ijms-20-01667" ref-type="bibr">26</xref>]; LC/ESI-QTOF-MS/MS [<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>]; Pre-column derivatization HPLC [<xref rid="B38-ijms-20-01667" ref-type="bibr">38</xref>]; GC [<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>]; <sup>1</sup>HNMR/<sup>13</sup>CNMR/HR-FAB-MS [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B18-ijms-20-01667" ref-type="bibr">18</xref>,<xref rid="B20-ijms-20-01667" ref-type="bibr">20</xref>]; HPLC-ELSD [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>,<xref rid="B27-ijms-20-01667" ref-type="bibr">27</xref>,<xref rid="B28-ijms-20-01667" ref-type="bibr">28</xref>,<xref rid="B29-ijms-20-01667" ref-type="bibr">29</xref>,<xref rid="B32-ijms-20-01667" ref-type="bibr">32</xref>,<xref rid="B36-ijms-20-01667" ref-type="bibr">36</xref>,<xref rid="B47-ijms-20-01667" ref-type="bibr">47</xref>,<xref rid="B51-ijms-20-01667" ref-type="bibr">51</xref>]; HSCCC-ELSD [<xref rid="B31-ijms-20-01667" ref-type="bibr">31</xref>]; UPLC-CAD/HPLC-ELSD [<xref rid="B42-ijms-20-01667" ref-type="bibr">42</xref>]; UHPLC-MS/MS [<xref rid="B59-ijms-20-01667" ref-type="bibr">59</xref>]; LC-LTQ-Orbitrap MS<sup>n</sup> [<xref rid="B22-ijms-20-01667" ref-type="bibr">22</xref>]; LC-TRAP-MS/LC-ESI-MS [<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>]; ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]; TLCS [<xref rid="B23-ijms-20-01667" ref-type="bibr">23</xref>,<xref rid="B48-ijms-20-01667" ref-type="bibr">48</xref>,<xref rid="B57-ijms-20-01667" ref-type="bibr">57</xref>]; <sup>13</sup>CNMR [<xref rid="B69-ijms-20-01667" ref-type="bibr">69</xref>]; Determination of colorimetry [<xref rid="B23-ijms-20-01667" ref-type="bibr">23</xref>]; RRLC-MS/MS [<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>]; MS/IR/<sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B75-ijms-20-01667" ref-type="bibr">75</xref>]; GC [<xref rid="B37-ijms-20-01667" ref-type="bibr">37</xref>]; GC direct [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>]; Indirect UV detection [<xref rid="B41-ijms-20-01667" ref-type="bibr">41</xref>]; Paper partition chromatography [<xref rid="B46-ijms-20-01667" ref-type="bibr">46</xref>]; Aid-dye ofnrimetry [<xref rid="B24-ijms-20-01667" ref-type="bibr">24</xref>,<xref rid="B39-ijms-20-01667" ref-type="bibr">39</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A2</td><td align="center" valign="middle" rowspan="1" colspan="1">Peiminine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>43</sub>NO<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">167691</td><td align="center" valign="middle" rowspan="1" colspan="1">429.645</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC-MS [<xref rid="B21-ijms-20-01667" ref-type="bibr">21</xref>]; HPLC-ELSD [<xref rid="B60-ijms-20-01667" ref-type="bibr">60</xref>]; HPLC-ESI/MS [<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>]; Pre-column derivatization HPLC [<xref rid="B38-ijms-20-01667" ref-type="bibr">38</xref>]; UPLC-ELSD [<xref rid="B26-ijms-20-01667" ref-type="bibr">26</xref>]; LC/ESI-QTOF-MS/MS [<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>]; GC [<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>]; <sup>1</sup>HNMR/<sup>13</sup>CNMR/HR-FAB-MS [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]; Acid dye two-phase titration [<xref rid="B50-ijms-20-01667" ref-type="bibr">50</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>,<xref rid="B18-ijms-20-01667" ref-type="bibr">18</xref>,<xref rid="B20-ijms-20-01667" ref-type="bibr">20</xref>]; HPLC-ELSD [<xref rid="B27-ijms-20-01667" ref-type="bibr">27</xref>,<xref rid="B28-ijms-20-01667" ref-type="bibr">28</xref>,<xref rid="B29-ijms-20-01667" ref-type="bibr">29</xref>,<xref rid="B32-ijms-20-01667" ref-type="bibr">32</xref>,<xref rid="B36-ijms-20-01667" ref-type="bibr">36</xref>,<xref rid="B47-ijms-20-01667" ref-type="bibr">47</xref>]; HPLC-CAD/HPLC-ELSD [<xref rid="B42-ijms-20-01667" ref-type="bibr">42</xref>]; HSCCC-ELSD [<xref rid="B31-ijms-20-01667" ref-type="bibr">31</xref>]; ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]; UHPLC&#x02013;MS/MS [<xref rid="B59-ijms-20-01667" ref-type="bibr">59</xref>]; TLCS [<xref rid="B23-ijms-20-01667" ref-type="bibr">23</xref>,<xref rid="B48-ijms-20-01667" ref-type="bibr">48</xref>,<xref rid="B57-ijms-20-01667" ref-type="bibr">57</xref>]; LC-LTQ-Orbitrap MS<sup>n</sup> [<xref rid="B22-ijms-20-01667" ref-type="bibr">22</xref>]; LC-TRAP-MS/LC-ESI-MS [<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>]; <sup>13</sup>CNMR [<xref rid="B69-ijms-20-01667" ref-type="bibr">69</xref>]; Determination of colorimetry [<xref rid="B23-ijms-20-01667" ref-type="bibr">23</xref>]; RRLC-MS/MS [<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>]; MS/IR/<sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B75-ijms-20-01667" ref-type="bibr">75</xref>]; GC [<xref rid="B37-ijms-20-01667" ref-type="bibr">37</xref>]; GC direct [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>]; Indirect UV detection [<xref rid="B41-ijms-20-01667" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A3</td><td align="center" valign="middle" rowspan="1" colspan="1">Zhebeinine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>45</sub>NO<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">21121503</td><td align="center" valign="middle" rowspan="1" colspan="1">431.661</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">TLC [<xref rid="B69-ijms-20-01667" ref-type="bibr">69</xref>]; <sup>13</sup>CNMR [<xref rid="B69-ijms-20-01667" ref-type="bibr">69</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A4</td><td align="center" valign="middle" rowspan="1" colspan="1">Zhebeinone</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>43</sub>NO<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">429.645</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B65-ijms-20-01667" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A5</td><td align="center" valign="middle" rowspan="1" colspan="1">Ebeiedine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>45</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">101324888</td><td align="center" valign="middle" rowspan="1" colspan="1">415.662</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>]; GC [<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>]; LC/ESI-QTOF-MS/MS [<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>]; <sup>1</sup>HNMR/<sup>13</sup>CNMR/HR-FAB-MS [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">GC [<xref rid="B37-ijms-20-01667" ref-type="bibr">37</xref>]; GC direct [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>]; LC-TRAP-MS/LC-ESI-MS [<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A6</td><td align="center" valign="middle" rowspan="1" colspan="1">Ebeiedinone</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>43</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">102062796</td><td align="center" valign="middle" rowspan="1" colspan="1">413.646</td><td align="center" valign="middle" rowspan="1" colspan="1">GC [<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>]; <sup>1</sup>HNMR/<sup>13</sup>CNMR/HR-FAB-MS [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">GC [<xref rid="B37-ijms-20-01667" ref-type="bibr">37</xref>]; GC direct [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>]; LC-TRAP-MS/LC-ESI-MS [<xref rid="B44-ijms-20-01667" ref-type="bibr">44</xref>]; LC-LTQ-Orbitrap MS<sup>n</sup> [<xref rid="B22-ijms-20-01667" ref-type="bibr">22</xref>]; HPLC-ELSD [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>,<xref rid="B36-ijms-20-01667" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A7</td><td align="center" valign="middle" rowspan="1" colspan="1">Isoverticine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>45</sub>NO<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">21573744</td><td align="center" valign="middle" rowspan="1" colspan="1">431.661</td><td align="center" valign="middle" rowspan="1" colspan="1">GC [<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>]; LC/ESI-QTOF-MS/MS [<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>]; <sup>1</sup>HNMR/<sup>13</sup>CNMR/HR-FAB-MS [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">GC [<xref rid="B37-ijms-20-01667" ref-type="bibr">37</xref>]; GC direct [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>]; LC-TRAP-MS/LC-ESI-MS [<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>]; HPLC-ELSD [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>,<xref rid="B36-ijms-20-01667" ref-type="bibr">36</xref>]; ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]; TLCS [<xref rid="B57-ijms-20-01667" ref-type="bibr">57</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A8</td><td align="center" valign="middle" rowspan="1" colspan="1">Suchengbeisine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>43</sub>NO<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">102112537</td><td align="center" valign="middle" rowspan="1" colspan="1">429.645</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>]; <sup>1</sup>HNMR/<sup>13</sup>CNMR/HR-FAB-MS [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A9</td><td align="center" valign="middle" rowspan="1" colspan="1">Peimisine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>41</sub>NO<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">161294</td><td align="center" valign="middle" rowspan="1" colspan="1">427.629</td><td align="center" valign="middle" rowspan="1" colspan="1">LC/ESI-QTOF-MS/MS [<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>]; UPLC-ELSD [<xref rid="B26-ijms-20-01667" ref-type="bibr">26</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-TRAP-MS/LC-ESI-MS [<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>]; HPLC-ELSD [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>,<xref rid="B36-ijms-20-01667" ref-type="bibr">36</xref>,<xref rid="B47-ijms-20-01667" ref-type="bibr">47</xref>]; TLC [<xref rid="B68-ijms-20-01667" ref-type="bibr">68</xref>]; TLCS [<xref rid="B57-ijms-20-01667" ref-type="bibr">57</xref>]; LC-LTQ-Orbitrap MS<sup>n</sup> [<xref rid="B22-ijms-20-01667" ref-type="bibr">22</xref>]; RRLC-MS/MS [<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A10</td><td align="center" valign="middle" rowspan="1" colspan="1">Peimisine-N-oxide</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>42</sub>NO<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF</td><td align="center" valign="middle" rowspan="1" colspan="1">444.636</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-LTQ-Orbitrap MS<sup>n</sup> [<xref rid="B22-ijms-20-01667" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A11</td><td align="center" valign="middle" rowspan="1" colspan="1">Zhebeininoside</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>33</sub>H<sub>55</sub>NO<sub>8</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">593.802</td><td align="center" valign="middle" rowspan="1" colspan="1">LC/ESI-QTOF-MS/MS [<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-TRAP-MS/LC-ESI-MS [<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>]; LC-LTQ-Orbitrap MS<sup>n</sup> [<xref rid="B22-ijms-20-01667" ref-type="bibr">22</xref>]; <sup>13</sup>CNMR/Infrared spectra analysis [<xref rid="B67-ijms-20-01667" ref-type="bibr">67</xref>]; ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A12</td><td align="center" valign="middle" rowspan="1" colspan="1">Verticinone-3-&#x003b2;-<sc>d</sc>-glucoside</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>33</sub>H<sub>53</sub>NO<sub>8</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">90479257</td><td align="center" valign="middle" rowspan="1" colspan="1">591.786</td><td align="center" valign="middle" rowspan="1" colspan="1">LC/ESI-QTOF-MS/MS [<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A13</td><td align="center" valign="middle" rowspan="1" colspan="1">Puqietinone</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>28</sub>H<sub>47</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">10693900</td><td align="center" valign="middle" rowspan="1" colspan="1">429.689</td><td align="center" valign="middle" rowspan="1" colspan="1">LC/ESI-QTOF-MS/MS [<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A14</td><td align="center" valign="middle" rowspan="1" colspan="1">Puqiedinone</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>43</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">126149</td><td align="center" valign="middle" rowspan="1" colspan="1">413.646</td><td align="center" valign="middle" rowspan="1" colspan="1">LC/ESI-QTOF-MS/MS [<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-TRAP-MS/LC-ESI-MS [<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>]; LC-LTQ-Orbitrap MS<sup>n</sup> [<xref rid="B22-ijms-20-01667" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A15</td><td align="center" valign="middle" rowspan="1" colspan="1">Puqiedine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>45</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">101400593</td><td align="center" valign="middle" rowspan="1" colspan="1">415.662</td><td align="center" valign="middle" rowspan="1" colspan="1">LC/ESI-QTOF-MS/MS [<xref rid="B72-ijms-20-01667" ref-type="bibr">72</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-TRAP-MS/LC-ESI-MS [<xref rid="B45-ijms-20-01667" ref-type="bibr">45</xref>]; ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A16</td><td align="center" valign="middle" rowspan="1" colspan="1">Eduardine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>43</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">413.646</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B66-ijms-20-01667" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A17</td><td align="center" valign="middle" rowspan="1" colspan="1">Zhebeirine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>43</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">413.646</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B66-ijms-20-01667" ref-type="bibr">66</xref>]; ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A18</td><td align="center" valign="middle" rowspan="1" colspan="1">2,3-deoxyladenosine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>10</sub>H<sub>11</sub>N<sub>5</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF</td><td align="center" valign="middle" rowspan="1" colspan="1">233.231</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A19</td><td align="center" valign="middle" rowspan="1" colspan="1">N-demethylpuqietinone</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>45</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">11304576</td><td align="center" valign="middle" rowspan="1" colspan="1">415.662</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A20</td><td align="center" valign="middle" rowspan="1" colspan="1">Puqienine B</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>28</sub>H<sub>45</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">11419389</td><td align="center" valign="middle" rowspan="1" colspan="1">443.672</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A21</td><td align="center" valign="middle" rowspan="1" colspan="1">Zhebeinone-3-&#x003b2;-<sc>d</sc>-glucoside</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>33</sub>H<sub>55</sub>NO<sub>8</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">593.802</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A22</td><td align="center" valign="middle" rowspan="1" colspan="1">Peiminoside</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>33</sub>H<sub>55</sub>NO<sub>7</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">90479565</td><td align="center" valign="middle" rowspan="1" colspan="1">577.803</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">Paper partition chromatography [<xref rid="B46-ijms-20-01667" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A23</td><td align="center" valign="middle" rowspan="1" colspan="1">Frithunbol A</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>41</sub>NO<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">443.628</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR/HR-FAB-MS [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A24</td><td align="center" valign="middle" rowspan="1" colspan="1">Frithunbol B</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>42</sub>NO<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">428.637</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR/HR-FAB-MS [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A25</td><td align="center" valign="middle" rowspan="1" colspan="1">Eduardinine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>27</sub>H<sub>45</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">415.662</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR/HR-FAB-MS [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x003b2;-hydroxy-5&#x003b1;-jervanin-12-en-6-one<break/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>27</sub>H<sub>42</sub>NO<sub>3</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">428.637</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR/HR-FAB-MS [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>B</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Compounds from essential oils (<italic>n</italic> = 29)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b4;-elemene</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">12309449</td><td align="center" valign="middle" rowspan="1" colspan="1">204.357</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b4;-selinene</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">520383</td><td align="center" valign="middle" rowspan="1" colspan="1">204.357</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B3</td><td align="center" valign="middle" rowspan="1" colspan="1">Tetradecanoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>14</sub>H<sub>28</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">11005</td><td align="center" valign="middle" rowspan="1" colspan="1">228.376</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B4</td><td align="center" valign="middle" rowspan="1" colspan="1">Pentadecanoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>15</sub>H<sub>30</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">13849</td><td align="center" valign="middle" rowspan="1" colspan="1">242.403</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B5</td><td align="center" valign="middle" rowspan="1" colspan="1">Hexadecanoic acid, methyl ester</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>17</sub>H<sub>34</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">8181</td><td align="center" valign="middle" rowspan="1" colspan="1">270.457</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>,<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B6</td><td align="center" valign="middle" rowspan="1" colspan="1">9-hexadecenoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>16</sub>H<sub>30</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">5282745</td><td align="center" valign="middle" rowspan="1" colspan="1">254.414</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B7</td><td align="center" valign="middle" rowspan="1" colspan="1">N-hexadecanoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>16</sub>H<sub>32</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">985</td><td align="center" valign="middle" rowspan="1" colspan="1">256.43</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B8</td><td align="center" valign="middle" rowspan="1" colspan="1">Kaur-15-ene</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>32</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">521318</td><td align="center" valign="middle" rowspan="1" colspan="1">272.476</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B9</td><td align="center" valign="middle" rowspan="1" colspan="1">Heptadecanoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>17</sub>H<sub>34</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">10465</td><td align="center" valign="middle" rowspan="1" colspan="1">270.457</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B10</td><td align="center" valign="middle" rowspan="1" colspan="1">Kaurene</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>32</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">91746569</td><td align="center" valign="middle" rowspan="1" colspan="1">272.476</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B11</td><td align="center" valign="middle" rowspan="1" colspan="1">9,12-Octadecadienoic acid (Z,Z)-, <break/>methyl ester</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>19</sub>H<sub>34</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">5284421</td><td align="center" valign="middle" rowspan="1" colspan="1">294.479</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B12</td><td align="center" valign="middle" rowspan="1" colspan="1">9-Tetradecenal, (Z)-</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>14</sub>H<sub>26</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">5364471</td><td align="center" valign="middle" rowspan="1" colspan="1">210.361</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B13</td><td align="center" valign="middle" rowspan="1" colspan="1">9,12-Octadecadienoic acid, methyl ester, (E, E)-<break/></td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>19</sub>H<sub>34</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">135058711</td><td align="center" valign="middle" rowspan="1" colspan="1">294.479</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B14</td><td align="center" valign="middle" rowspan="1" colspan="1">Oleic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>34</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">445639</td><td align="center" valign="middle" rowspan="1" colspan="1">282.468</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B15</td><td align="center" valign="middle" rowspan="1" colspan="1">Linoleic acid, ethyl ester</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>2036</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">5282184</td><td align="center" valign="middle" rowspan="1" colspan="1">308.506</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B16-ijms-20-01667" ref-type="bibr">16</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B16</td><td align="center" valign="middle" rowspan="1" colspan="1">Butylated hydroxytoluene</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">31404</td><td align="center" valign="middle" rowspan="1" colspan="1">220.356</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS (Du et al., 2018)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B17</td><td align="center" valign="middle" rowspan="1" colspan="1">L-(+)-Ascorbic acid 2,6-<break/>dihexadecanoate</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>38</sub>H<sub>68</sub>O<sub>8</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">54722209</td><td align="center" valign="middle" rowspan="1" colspan="1">652.954</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS (Du et al., 2018)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B18</td><td align="center" valign="middle" rowspan="1" colspan="1">Ethyl 9-hexadecenoate</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>34</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">5364759</td><td align="center" valign="middle" rowspan="1" colspan="1">282.468</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B19</td><td align="center" valign="middle" rowspan="1" colspan="1">Hexadecanoic acid, ethyl ester</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>36</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">12366</td><td align="center" valign="middle" rowspan="1" colspan="1">284.484</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B20</td><td align="center" valign="middle" rowspan="1" colspan="1">1H-Naphtho [2,1-B] pyran, 3-ethenyldodecahydro-3,4a,7,7,10a-pentamethyl-<break/></td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>34</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">273540178</td><td align="center" valign="middle" rowspan="1" colspan="1">290.491</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B21</td><td align="center" valign="middle" rowspan="1" colspan="1">Kaur-16-ene</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>32</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">520687</td><td align="center" valign="middle" rowspan="1" colspan="1">272.476</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B22</td><td align="center" valign="middle" rowspan="1" colspan="1">9,11-Octadecadienoic acid, methyl ester, (E, E)-<break/></td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>19</sub>H<sub>34</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">319301067</td><td align="center" valign="middle" rowspan="1" colspan="1">294.479</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B23</td><td align="center" valign="middle" rowspan="1" colspan="1">9,12-Octadecadienoic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>32</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">5282457</td><td align="center" valign="middle" rowspan="1" colspan="1">280.452</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B24</td><td align="center" valign="middle" rowspan="1" colspan="1">Linoleic acid, ethyl ester</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>36</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">5282184</td><td align="center" valign="middle" rowspan="1" colspan="1">308.506</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B25</td><td align="center" valign="middle" rowspan="1" colspan="1">Octadecanoic acid, ethyl ester</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>40</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">8122</td><td align="center" valign="middle" rowspan="1" colspan="1">312.538</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B26</td><td align="center" valign="middle" rowspan="1" colspan="1">2(1H)-Phenanthrenone, 3,4,4a,4b,5,6,7,8,10,10a-decahydro-<break/>1,1,4a,7,7-pentamethyl, [4aR-(4a.&#x003b1;., 4b.&#x003b2;.,10a.&#x003b2;.)]-</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>19</sub>H<sub>30</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">621255</td><td align="center" valign="middle" rowspan="1" colspan="1">274.448</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B27</td><td align="center" valign="middle" rowspan="1" colspan="1">3-Methyleneandrostan-17-ol</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>32</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">625647</td><td align="center" valign="middle" rowspan="1" colspan="1">288.475</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">B28</td><td align="center" valign="middle" rowspan="1" colspan="1">Androst-4-en-3-one, 17-hydroxy-, (17.&#x003b2;.)<break/></td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>19</sub>H<sub>28</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">50049744</td><td align="center" valign="middle" rowspan="1" colspan="1">288.431</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Podocarp-7-en-3.&#x003b2;.-ol, 13.&#x003b2;.-methyl-13-vinyl-<break/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>20</sub>H<sub>32</sub>O</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">620519</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288.475</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GC-MS [<xref rid="B25-ijms-20-01667" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>C</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Diterpenoids (<italic>n</italic> = 13)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C1</td><td align="center" valign="middle" rowspan="1" colspan="1">Isopimaran-19-ol</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>32</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">75399514</td><td align="center" valign="middle" rowspan="1" colspan="1">288.475</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B35-ijms-20-01667" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C2</td><td align="center" valign="middle" rowspan="1" colspan="1">Isopimaran-19-oic acid, methyl ester</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>21</sub>H<sub>32</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">316.485</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>,<xref rid="B35-ijms-20-01667" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C3</td><td align="center" valign="middle" rowspan="1" colspan="1">Ent-kauran-16&#x003b2;, 17-diol</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>34</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">306.49</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">TLC [<xref rid="B68-ijms-20-01667" ref-type="bibr">68</xref>]; <sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>,<xref rid="B35-ijms-20-01667" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C4</td><td align="center" valign="middle" rowspan="1" colspan="1">Ent-kauran-16&#x003b1;, 17-diol</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>34</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">306.49</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>,<xref rid="B35-ijms-20-01667" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C5</td><td align="center" valign="middle" rowspan="1" colspan="1">Ent-16&#x003b2;, 17-epoxy-kaurane</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>32</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">79592848</td><td align="center" valign="middle" rowspan="1" colspan="1">288.475</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B35-ijms-20-01667" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C6</td><td align="center" valign="middle" rowspan="1" colspan="1">Ent-16&#x003b1;-methoxy-kauran-17-ol</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>21</sub>H<sub>36</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">51842049</td><td align="center" valign="middle" rowspan="1" colspan="1">320.517</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B35-ijms-20-01667" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C7</td><td align="center" valign="middle" rowspan="1" colspan="1">Ent-kaur-15-en-17-ol</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>32</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">3082069</td><td align="center" valign="middle" rowspan="1" colspan="1">288.475</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B35-ijms-20-01667" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C8</td><td align="center" valign="middle" rowspan="1" colspan="1">Trans-communol</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>32</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">51909318</td><td align="center" valign="middle" rowspan="1" colspan="1">288.475</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C9</td><td align="center" valign="middle" rowspan="1" colspan="1">Trans-comminic acid, methyl ester</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>21</sub>H<sub>32</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">316.485</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C10</td><td align="center" valign="middle" rowspan="1" colspan="1">Ent-17-norkauran-16-one</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>19</sub>H<sub>30</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">12740861</td><td align="center" valign="middle" rowspan="1" colspan="1">274.448</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C11</td><td align="center" valign="middle" rowspan="1" colspan="1">Ent-15&#x003b2;,16-epoxy-kauran-17-ol</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>20</sub>H<sub>32</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">51511087</td><td align="center" valign="middle" rowspan="1" colspan="1">304.474</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C12</td><td align="center" valign="middle" rowspan="1" colspan="1">Ent-16&#x003b2;-hydroxy-kauran-17-yl ent-kaur-15-en-17-oate</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>40</sub>H<sub>63</sub>O<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF (<xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>)</td><td align="center" valign="middle" rowspan="1" colspan="1">591.941</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ent-(16S)-atisan-13, 17-oxide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>20</sub>H<sub>32</sub>O</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50418337</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288.475</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B34-ijms-20-01667" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>D</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Carbohydrates (<italic>n</italic> = 2)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">D1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-<sc>d</sc>-glucose4-1&#x003b2;-<sc>d</sc>-galactose</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>12</sub>H<sub>22</sub>O<sub>11</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">NF</td><td align="center" valign="middle" rowspan="1" colspan="1">342.297</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC-ELSD [<xref rid="B19-ijms-20-01667" ref-type="bibr">19</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sucrose</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>12</sub>H<sub>22</sub>O<sub>11</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5988</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">342.297</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPLC-ELSD [<xref rid="B19-ijms-20-01667" ref-type="bibr">19</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>E</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Sterols (<italic>n</italic> = 2)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">E1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-sitosterol</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>29</sub>H<sub>50</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">222284</td><td align="center" valign="middle" rowspan="1" colspan="1">414.718</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">TLC [<xref rid="B68-ijms-20-01667" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Daucosterol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>35</sub>H<sub>60</sub>O<sub>6</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5742590</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">576.859</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TLC [<xref rid="B68-ijms-20-01667" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>F</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Amino acids (<italic>n</italic> = 18)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F1</td><td align="center" valign="middle" rowspan="1" colspan="1">Glycine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>2</sub>H<sub>5</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">750</td><td align="center" valign="middle" rowspan="1" colspan="1">75.067</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F2</td><td align="center" valign="middle" rowspan="1" colspan="1">Leucine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>6</sub>H<sub>13</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">6106</td><td align="center" valign="middle" rowspan="1" colspan="1">131.175</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F3</td><td align="center" valign="middle" rowspan="1" colspan="1">Methionine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>5</sub>H<sub>11</sub>NO<sub>2</sub>S</td><td align="center" valign="middle" rowspan="1" colspan="1">6137</td><td align="center" valign="middle" rowspan="1" colspan="1">149.208</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F4</td><td align="center" valign="middle" rowspan="1" colspan="1">Tyrosine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>9</sub>H<sub>11</sub>NO<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">6057</td><td align="center" valign="middle" rowspan="1" colspan="1">181.191</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F5</td><td align="center" valign="middle" rowspan="1" colspan="1">Histidine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>6</sub>H<sub>9</sub>N<sub>3</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">6274</td><td align="center" valign="middle" rowspan="1" colspan="1">155.157</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F6</td><td align="center" valign="middle" rowspan="1" colspan="1">Threonine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>4</sub>H<sub>9</sub>NO<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">6288</td><td align="center" valign="middle" rowspan="1" colspan="1">119.12</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F7</td><td align="center" valign="middle" rowspan="1" colspan="1">Alanine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>3</sub>H<sub>7</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">5950</td><td align="center" valign="middle" rowspan="1" colspan="1">89.094</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F8</td><td align="center" valign="middle" rowspan="1" colspan="1">Isoleucine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>6</sub>H<sub>13</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">6306</td><td align="center" valign="middle" rowspan="1" colspan="1">131.175</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F9</td><td align="center" valign="middle" rowspan="1" colspan="1">Tryptophan</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>11</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">6305</td><td align="center" valign="middle" rowspan="1" colspan="1">204.229</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F10</td><td align="center" valign="middle" rowspan="1" colspan="1">Cystine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>6</sub>H<sub>12</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">67678</td><td align="center" valign="middle" rowspan="1" colspan="1">240.292</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F11</td><td align="center" valign="middle" rowspan="1" colspan="1">Lysine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>6</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">5962</td><td align="center" valign="middle" rowspan="1" colspan="1">146.19</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F12</td><td align="center" valign="middle" rowspan="1" colspan="1">Aspartic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>4</sub>H<sub>7</sub>NO<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">5960</td><td align="center" valign="middle" rowspan="1" colspan="1">133.103</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F13</td><td align="center" valign="middle" rowspan="1" colspan="1">Valine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>5</sub>H<sub>11</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">6287</td><td align="center" valign="middle" rowspan="1" colspan="1">117.148</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F14</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenylalanine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>8</sub>H<sub>8</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">6140</td><td align="center" valign="middle" rowspan="1" colspan="1">165.192</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F15</td><td align="center" valign="middle" rowspan="1" colspan="1">Proline</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>5</sub>H<sub>9</sub>NO<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">145742</td><td align="center" valign="middle" rowspan="1" colspan="1">115.132</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F16</td><td align="center" valign="middle" rowspan="1" colspan="1">Serine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>3</sub>H<sub>7</sub>NO<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">5951</td><td align="center" valign="middle" rowspan="1" colspan="1">105.093</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F17</td><td align="center" valign="middle" rowspan="1" colspan="1">Glutamic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>5</sub>H<sub>9</sub>NO<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">33032</td><td align="center" valign="middle" rowspan="1" colspan="1">147.13</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arginine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>6</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6322</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">174.204</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>G</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Nucleosides (<italic>n</italic> = 6)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">G1</td><td align="center" valign="middle" rowspan="1" colspan="1">Uridine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>9</sub>H<sub>12</sub>N<sub>2</sub>O<sub>6</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">6029</td><td align="center" valign="middle" rowspan="1" colspan="1">244.203</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-ESI-MS<sup>n</sup> [<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>]; HPLC-UV-ESI/MS [<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>]; HPLC [<xref rid="B71-ijms-20-01667" ref-type="bibr">71</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">G2</td><td align="center" valign="middle" rowspan="1" colspan="1">Guanosine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>10</sub>H<sub>13</sub>N<sub>5</sub>O<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">6802</td><td align="center" valign="middle" rowspan="1" colspan="1">283.244</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-ESI-MS<sup>n</sup> (Zhang, 2008); HPLC-UV-ESI/MS [<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>]; HPLC [<xref rid="B71-ijms-20-01667" ref-type="bibr">71</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">G3</td><td align="center" valign="middle" rowspan="1" colspan="1">Adenosine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>10</sub>H<sub>13</sub>N<sub>5</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">60961</td><td align="center" valign="middle" rowspan="1" colspan="1">267.245</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-ESI-MS<sup>n</sup> (Zhang, 2008); HPLC-UV-ESI/MS [<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>]; HPLC [<xref rid="B71-ijms-20-01667" ref-type="bibr">71</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">G4</td><td align="center" valign="middle" rowspan="1" colspan="1">Thymidine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>10</sub>H<sub>14</sub>N<sub>2</sub>O<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">5789</td><td align="center" valign="middle" rowspan="1" colspan="1">242.231</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-ESI-MS<sup>n</sup> [<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>]; HPLC-UV-ESI/MS [<xref rid="B70-ijms-20-01667" ref-type="bibr">70</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">G5</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytidine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>9</sub>H<sub>13</sub>N<sub>3</sub>O<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">6175</td><td align="center" valign="middle" rowspan="1" colspan="1">243.219</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inosine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>10</sub>H<sub>12</sub>N<sub>4</sub>O<sub>5</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6021</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">268.229</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>H</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Nucleobases (<italic>n</italic> = 4)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">H1</td><td align="center" valign="middle" rowspan="1" colspan="1">Adenine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>5</sub>H<sub>5</sub>N<sub>5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">190</td><td align="center" valign="middle" rowspan="1" colspan="1">135.13</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-ESI-MS<sup>n</sup> (Zhang, 2008); HPLC-UV-ESI/MS (Zhang, 2008)</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">H2</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypoxanthine</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>5</sub>H<sub>4</sub>N<sub>4</sub>O</td><td align="center" valign="middle" rowspan="1" colspan="1">790</td><td align="center" valign="middle" rowspan="1" colspan="1">136.114</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">H3</td><td align="center" valign="middle" rowspan="1" colspan="1">Uracil</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>4</sub>H<sub>4</sub>N<sub>2</sub>O<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">1174</td><td align="center" valign="middle" rowspan="1" colspan="1">112.088</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thymine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>5</sub>H<sub>6</sub>N<sub>2</sub>O<sub>2</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1135</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">126.115</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HPLC [<xref rid="B64-ijms-20-01667" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>I</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Fatty acids (<italic>n</italic> = 4)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">I1</td><td align="center" valign="middle" rowspan="1" colspan="1">Vernolic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>32</sub>O<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">6449780</td><td align="center" valign="middle" rowspan="1" colspan="1">296.451</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">I2</td><td align="center" valign="middle" rowspan="1" colspan="1">2-monopalmitin</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>19</sub>H<sub>38</sub>O<sub>4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">123409</td><td align="center" valign="middle" rowspan="1" colspan="1">330.509</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">I3</td><td align="center" valign="middle" rowspan="1" colspan="1">13(R)-hydroxy-octadeca-(9Z,11E<break/>,15Z)-trien-oic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18</sub>H<sub>30</sub>O<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">643726</td><td align="center" valign="middle" rowspan="1" colspan="1">294.435</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Picropodophyllotoxin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>22</sub>H<sub>22</sub>O<sub>8</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72435</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">414.41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>13</sup>CNMR/Infrared spectra analysis [<xref rid="B67-ijms-20-01667" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>J</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Lignans (<italic>n</italic> = 3)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">J1</td><td align="center" valign="middle" rowspan="1" colspan="1">Octahydrocurcumin</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>21</sub>H<sub>28</sub>O<sub>6</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">11068834</td><td align="center" valign="middle" rowspan="1" colspan="1">376.449</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">J2</td><td align="center" valign="middle" rowspan="1" colspan="1">Zhebeiresinol</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>14</sub>H<sub>16</sub>O<sub>6</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">192547</td><td align="center" valign="middle" rowspan="1" colspan="1">280.276</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]; <sup>1</sup>HNMR/<sup>13</sup>CNMR [<xref rid="B30-ijms-20-01667" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">J3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sauriol B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>21</sub>H<sub>28</sub>O<sub>6</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15965508</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">376.449</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ESI-MS [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>K</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Elements (<italic>n</italic> = 27)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K1</td><td align="center" valign="middle" rowspan="1" colspan="1">Aluminum</td><td align="center" valign="middle" rowspan="1" colspan="1">Al</td><td align="center" valign="middle" rowspan="1" colspan="1">5359268</td><td align="center" valign="middle" rowspan="1" colspan="1">26.982</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-OES [<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">FAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K2</td><td align="center" valign="middle" rowspan="1" colspan="1">Arsenic</td><td align="center" valign="middle" rowspan="1" colspan="1">As</td><td align="center" valign="middle" rowspan="1" colspan="1">5359596</td><td align="center" valign="middle" rowspan="1" colspan="1">74.922</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>]; ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B74-ijms-20-01667" ref-type="bibr">74</xref>]; ICP-OES [<xref rid="B15-ijms-20-01667" ref-type="bibr">15</xref>]; ICAP [<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>]; FAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K3</td><td align="center" valign="middle" rowspan="1" colspan="1">Boron</td><td align="center" valign="middle" rowspan="1" colspan="1">B</td><td align="center" valign="middle" rowspan="1" colspan="1">5462311</td><td align="center" valign="middle" rowspan="1" colspan="1">10.81</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>,<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K4</td><td align="center" valign="middle" rowspan="1" colspan="1">Barium</td><td align="center" valign="middle" rowspan="1" colspan="1">Ba</td><td align="center" valign="middle" rowspan="1" colspan="1">5355457</td><td align="center" valign="middle" rowspan="1" colspan="1">137.327</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>]; ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K5</td><td align="center" valign="middle" rowspan="1" colspan="1">Bismuth</td><td align="center" valign="middle" rowspan="1" colspan="1">Bi</td><td align="center" valign="middle" rowspan="1" colspan="1">5359367</td><td align="center" valign="middle" rowspan="1" colspan="1">208.98</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K6</td><td align="center" valign="middle" rowspan="1" colspan="1">Calcium</td><td align="center" valign="middle" rowspan="1" colspan="1">Ca</td><td align="center" valign="middle" rowspan="1" colspan="1">5460341</td><td align="center" valign="middle" rowspan="1" colspan="1">40.078</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-OES [<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">FAAS [<xref rid="B52-ijms-20-01667" ref-type="bibr">52</xref>,<xref rid="B53-ijms-20-01667" ref-type="bibr">53</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K7</td><td align="center" valign="middle" rowspan="1" colspan="1">Cadmium</td><td align="center" valign="middle" rowspan="1" colspan="1">Cd</td><td align="center" valign="middle" rowspan="1" colspan="1">23973</td><td align="center" valign="middle" rowspan="1" colspan="1">112.414</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>]; ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>,<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B74-ijms-20-01667" ref-type="bibr">74</xref>]; ICP-OES [<xref rid="B15-ijms-20-01667" ref-type="bibr">15</xref>]; ICAP [<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>]; FAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; AAS [<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K8</td><td align="center" valign="middle" rowspan="1" colspan="1">Cobalt</td><td align="center" valign="middle" rowspan="1" colspan="1">Co</td><td align="center" valign="middle" rowspan="1" colspan="1">104730</td><td align="center" valign="middle" rowspan="1" colspan="1">58.933</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>]; ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">FAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K9</td><td align="center" valign="middle" rowspan="1" colspan="1">Chromium</td><td align="center" valign="middle" rowspan="1" colspan="1">Cr</td><td align="center" valign="middle" rowspan="1" colspan="1">23976</td><td align="center" valign="middle" rowspan="1" colspan="1">51.996</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">FAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; AAS [<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K10</td><td align="center" valign="middle" rowspan="1" colspan="1">Copper</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu</td><td align="center" valign="middle" rowspan="1" colspan="1">23978</td><td align="center" valign="middle" rowspan="1" colspan="1">63.546</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>,<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>]; ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B74-ijms-20-01667" ref-type="bibr">74</xref>]; ICP-OES [<xref rid="B15-ijms-20-01667" ref-type="bibr">15</xref>]; ICAP [<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>]; FAAS [<xref rid="B52-ijms-20-01667" ref-type="bibr">52</xref>,<xref rid="B53-ijms-20-01667" ref-type="bibr">53</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; AAS [<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K11</td><td align="center" valign="middle" rowspan="1" colspan="1">Iron</td><td align="center" valign="middle" rowspan="1" colspan="1">Fe</td><td align="center" valign="middle" rowspan="1" colspan="1">23925</td><td align="center" valign="middle" rowspan="1" colspan="1">55.845</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>,<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>]; ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B74-ijms-20-01667" ref-type="bibr">74</xref>]; FAAS [<xref rid="B52-ijms-20-01667" ref-type="bibr">52</xref>,<xref rid="B53-ijms-20-01667" ref-type="bibr">53</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; AAS [<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K12</td><td align="center" valign="middle" rowspan="1" colspan="1">Mercury</td><td align="center" valign="middle" rowspan="1" colspan="1">Hg</td><td align="center" valign="middle" rowspan="1" colspan="1">23931</td><td align="center" valign="middle" rowspan="1" colspan="1">200.592</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>]; ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-OES [<xref rid="B15-ijms-20-01667" ref-type="bibr">15</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K13</td><td align="center" valign="middle" rowspan="1" colspan="1">Indium</td><td align="center" valign="middle" rowspan="1" colspan="1">In</td><td align="center" valign="middle" rowspan="1" colspan="1">5359967</td><td align="center" valign="middle" rowspan="1" colspan="1">114.818</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K14</td><td align="center" valign="middle" rowspan="1" colspan="1">Potassium</td><td align="center" valign="middle" rowspan="1" colspan="1">K</td><td align="center" valign="middle" rowspan="1" colspan="1">5462222</td><td align="center" valign="middle" rowspan="1" colspan="1">39.098</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-OES [<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">FAAS [<xref rid="B53-ijms-20-01667" ref-type="bibr">53</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K15</td><td align="center" valign="middle" rowspan="1" colspan="1">Lithium</td><td align="center" valign="middle" rowspan="1" colspan="1">Li</td><td align="center" valign="middle" rowspan="1" colspan="1">3028194</td><td align="center" valign="middle" rowspan="1" colspan="1">6.94</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K16</td><td align="center" valign="middle" rowspan="1" colspan="1">Magnesium</td><td align="center" valign="middle" rowspan="1" colspan="1">Mg</td><td align="center" valign="middle" rowspan="1" colspan="1">5462224</td><td align="center" valign="middle" rowspan="1" colspan="1">24.305</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>]; ICP-OES [<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">FAAS [<xref rid="B53-ijms-20-01667" ref-type="bibr">53</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; AAS [<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K17</td><td align="center" valign="middle" rowspan="1" colspan="1">Manganese</td><td align="center" valign="middle" rowspan="1" colspan="1">Mn</td><td align="center" valign="middle" rowspan="1" colspan="1">23930</td><td align="center" valign="middle" rowspan="1" colspan="1">54.938</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>,<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>]; ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B74-ijms-20-01667" ref-type="bibr">74</xref>]; FAAS [<xref rid="B53-ijms-20-01667" ref-type="bibr">53</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; ICAP [<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K18</td><td align="center" valign="middle" rowspan="1" colspan="1">Molybdenum</td><td align="center" valign="middle" rowspan="1" colspan="1">Mo</td><td align="center" valign="middle" rowspan="1" colspan="1">23932</td><td align="center" valign="middle" rowspan="1" colspan="1">95.95</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-OES [<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K19</td><td align="center" valign="middle" rowspan="1" colspan="1">Sodium</td><td align="center" valign="middle" rowspan="1" colspan="1">Na</td><td align="center" valign="middle" rowspan="1" colspan="1">5360545</td><td align="center" valign="middle" rowspan="1" colspan="1">22.99</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-OES [<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">FAAS [<xref rid="B53-ijms-20-01667" ref-type="bibr">53</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K20</td><td align="center" valign="middle" rowspan="1" colspan="1">Nickel</td><td align="center" valign="middle" rowspan="1" colspan="1">Ni</td><td align="center" valign="middle" rowspan="1" colspan="1">935</td><td align="center" valign="middle" rowspan="1" colspan="1">58.693</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>]; ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>,<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">ICAP [<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K21</td><td align="center" valign="middle" rowspan="1" colspan="1">Phosphorus</td><td align="center" valign="middle" rowspan="1" colspan="1">P</td><td align="center" valign="middle" rowspan="1" colspan="1">5462309</td><td align="center" valign="middle" rowspan="1" colspan="1">30.974</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-OES [<xref rid="B62-ijms-20-01667" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K22</td><td align="center" valign="middle" rowspan="1" colspan="1">Lead</td><td align="center" valign="middle" rowspan="1" colspan="1">Pb</td><td align="center" valign="middle" rowspan="1" colspan="1">5352425</td><td align="center" valign="middle" rowspan="1" colspan="1">207.2</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>]; ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-OES [<xref rid="B15-ijms-20-01667" ref-type="bibr">15</xref>]; AAS [<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>]; ICAP [<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K23</td><td align="center" valign="middle" rowspan="1" colspan="1">Sulfur</td><td align="center" valign="middle" rowspan="1" colspan="1">S</td><td align="center" valign="middle" rowspan="1" colspan="1">5362487</td><td align="center" valign="middle" rowspan="1" colspan="1">32.06</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K24</td><td align="center" valign="middle" rowspan="1" colspan="1">Selenium</td><td align="center" valign="middle" rowspan="1" colspan="1">Se</td><td align="center" valign="middle" rowspan="1" colspan="1">6326970</td><td align="center" valign="middle" rowspan="1" colspan="1">78.971</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">Spectrophotometry [<xref rid="B54-ijms-20-01667" ref-type="bibr">54</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K25</td><td align="center" valign="middle" rowspan="1" colspan="1">Strontium</td><td align="center" valign="middle" rowspan="1" colspan="1">Sr</td><td align="center" valign="middle" rowspan="1" colspan="1">5359327</td><td align="center" valign="middle" rowspan="1" colspan="1">87.62</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>,<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>]; ICP-OES</td><td align="center" valign="middle" rowspan="1" colspan="1">FAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K26</td><td align="center" valign="middle" rowspan="1" colspan="1">Vanadium</td><td align="center" valign="middle" rowspan="1" colspan="1">V</td><td align="center" valign="middle" rowspan="1" colspan="1">23990</td><td align="center" valign="middle" rowspan="1" colspan="1">50.941</td><td align="center" valign="middle" rowspan="1" colspan="1">ICP-AES [<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zinc</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zn</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23994</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65.379</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ICP-AES [<xref rid="B43-ijms-20-01667" ref-type="bibr">43</xref>,<xref rid="B58-ijms-20-01667" ref-type="bibr">58</xref>]; ICP-OES [<xref rid="B14-ijms-20-01667" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ICP-AES [<xref rid="B74-ijms-20-01667" ref-type="bibr">74</xref>]; ICP-OES; ICAP [<xref rid="B55-ijms-20-01667" ref-type="bibr">55</xref>]; FAAS [<xref rid="B52-ijms-20-01667" ref-type="bibr">52</xref>,<xref rid="B53-ijms-20-01667" ref-type="bibr">53</xref>,<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; GFAAS [<xref rid="B61-ijms-20-01667" ref-type="bibr">61</xref>]; AAS [<xref rid="B40-ijms-20-01667" ref-type="bibr">40</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Note: N/A: Not applicable; NF: Not found; SRV: Studies reporting a voucher number; SNRV: Studies not reporting voucher number; Corresponding molecular structures refer to PubChem and <xref ref-type="fig" rid="ijms-20-01667-f002">Figure 2</xref>.</p></fn></table-wrap-foot></table-wrap><table-wrap id="ijms-20-01667-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-20-01667-t002_Table 2</object-id><label>Table 2</label><caption><p>Characteristics of the 23 included studies relevant to the mechanisms of actions of Fritillariae Thunbergii Bulbus.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pharmacological Effects/<break/>Included Studies</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extract</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Characteristics of the Sample</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Interventions</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Primary Results</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>1. Anti-cancer</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Li et al., 2013 [<xref rid="B80-ijms-20-01667" ref-type="bibr">80</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total alkaloids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human lung adenocarcinoma parental cells A549; Resistant cells A549/DDP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity: FTB 12.5, 25, 50, 100, 200 mg/L and vehicle 0.5% CMC-Na.<break/>Multidrug resistance reversal effect: FTB 9 mg/L, cyclosporine A 1 mg/L or tetrandrine 1 mg/L plus DDP (final concentration: 0.01, 0.1, 1, 10, 100 mg/L).<break/>MDR1 mRNA and P-gp expression: A549/DDP + vehicle; A549/DDP + FTB 9 mg/L; A549/DDP + DDP 14 mg/L; A549/DDP + DDP 14 mg/L + FTB 9 mg/L; A549 + vehicle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub> of TAF to A549: 141 &#x000b1; 5 mg/L; <break/>IC<sub>50</sub> of TAF to A549/DDP: 298 &#x000b1; 22 mg/L; <break/>FTB was superior to closporine A and tetrandrines in increasing the reversal fold;<break/>FTB alone was superior to vehicle in decreasing the MDR1 mRNA and P-gp expression.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total alkaloids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 BALB/c nude mice (A549/DDP model)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vehicle 0.5% CMC-Na; DDP 5 mg/kg, ig, qd; TAF 2 mg/kg, ig, qd; DDP 5 mg/kg + FTB 0.5 mg/kg, ig, qd; DDP 5 mg/kg + FTB 1 mg/kg, ig, qd; DDP 5 mg/kg + FTB 2 mg/kg, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DDP + TAF was superior to DDP alone in increasing the tumor inhibitory rate.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liu et al., 2015 [<xref rid="B9-ijms-20-01667" ref-type="bibr">9</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total alkaloids; Total nucleosides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human hepatocellular carcinoma cell line HepG2, Resistant cell line HepG2/MDR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control; P-gp positive inhibitor verapamil; Total alkaloid, nucleoside, or polysaccharide 5 &#x003bc;g/mL respectively; Total alkaloid, nucleoside, or polysaccharide 50 &#x003bc;g/mL respectively</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total alkaloids or Total nucleosides in FTB was superior to the control in increasing the restriction of efflux activity of P-gp.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yang et al., 2005 [<xref rid="B91-ijms-20-01667" ref-type="bibr">91</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human lung adenocarcinoma parental cells LM<sub>2</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control; FZ + FTB (75 + 75, 25 + 25, 5 + 5, 1 + 1 mg/mL respectively); FZ (75, 25, 5 mg/mL respectively); FTB (75, 25, 5 mg/mL respectively)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTB alone was superior to control and FZ + FTB in increasing the apoptosis rate.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">142 SPF C<sub>57</sub> mice (Human lung adenocarcinoma parental cells LM<sub>2</sub> model)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control; FZ + FTB (0.8 + 1.6 g/kg, 0.64 + 1.28 g/kg, 0.51 + 1.02 g/kg respectively, ig, qd); FZ (0.8 g/kg, 0.64 g/kg, 0.51 g/kg respectively, ig, qd); FTB (1.6 g/kg, 1.28 g/kg, 1.02 g/kg respectively, ig, qd)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTB alone was superior to control and FZ + FTB in increasing the tumor inhibitory rate and reducing the number of metastases.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tong, 2016 [<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine; Peiminine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human breast carcinoma cells MCF-7; Resistant cell line MCF-7/ADM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine 12.5&#x02013;400 &#x003bc;g/mL; Peiminine 12.5&#x02013;400 &#x003bc;g/mL; ADM (0.78125&#x02013;100 &#x003bc;g/mL) + Peimine or Peiminine; Paclitaxel (2.5&#x02013;80 &#x003bc;g/mL) + Peimine or Peiminine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Both peimine and peiminine could reverse the multi-drug resistant tumor resistance of ADM or paclitaxel</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>2. Tracheobronchial relaxation</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chan, 2000 [<xref rid="B17-ijms-20-01667" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine; Peiminine; Ebeiedine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rat tracheal and bronchial rings</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine, Peiminine, Ebeiedine, Imperialine, puqietinone, Salbutamol, Diphenhydramine, Codeine cumulative concentrations 1 nM-100 &#x003bc;M respectively</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immediate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine, peiminine, ebeiedine and puqietinone in FTB could relax the tracheobronch of rats.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wu et al., 2018 [<xref rid="B56-ijms-20-01667" ref-type="bibr">56</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total alkaloids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rat tracheal and bronchial rings</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total alkaloids cumulative concentrations 0-3 g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immediate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total alkaloids in FTB were superior to control in increasing the pD<sub>2</sub> value.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>3. Antitussive</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yan et al., 2012 [<xref rid="B90-ijms-20-01667" ref-type="bibr">90</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Micro powders</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44 guinea pigs (citric acid induced cough model)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control: purified water, ig,qd; AZTB: 1.5 g/kg, ig, qd; FTB: 1.5 g/kg, ig, qd; Codeine phosphate: 0.02 g/kg, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 min</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTB was superior to control in reduding the frequency of cough and prolonging the remission period.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yan et al., 2012 [<xref rid="B89-ijms-20-01667" ref-type="bibr">89</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Micro powders</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53 guinea pigs (citric acid induced cough model)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control: purified water, ig,qd; FTB: 1.5 g/kg, ig, qd; AZTB: 1.5 g/kg, ig, qd; WBBM: 1.5 g/kg, ig, qd; Codeine phosphate: 0.02 g/kg, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 min</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTB was superior to control in reduding the frequency of cough and prolonging the remission period.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guo, 2007 [<xref rid="B27-ijms-20-01667" ref-type="bibr">27</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">140 Kunming mice (ammonium hydroxide induced cough model)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control: NS, ig,qd; FTB: 0.026, 0.052, 0.104 g/kg respectively, ig, qd; Codeine phosphate: 0.03 g/kg, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTB harvested in all four places was superior to control in reduding the frequency of cough and prolonging the remission period.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>4. Expectorant</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yan et al., 2012 [<xref rid="B89-ijms-20-01667" ref-type="bibr">89</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fine powders</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control: purified water, ig,qd; FTB: 2 g/kg, ig, qd; AZTB: 2 g/kg, ig, qd; WBBM: 2 g/kg, ig, qd; Ammonium chloride: 1 g/kg, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fine powders of FTB was superior to control in reducing the amount of phlegm secretion.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wang et al., 1993 [<xref rid="B86-ijms-20-01667" ref-type="bibr">86</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 Wistar rats</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Control: starch paste, 15 g/kg, ig,qd; FTB: 15 g/kg, ig, qd; CBM: 15 g/kg, ig, qd; WBM: 15 g/kg, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract of FTB was superior to control in reducing the amount of phlegm secretion.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>5. Anti-inflammation</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kim et al., 2016 [<xref rid="B33-ijms-20-01667" ref-type="bibr">33</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine; Ebeiedine; Suchengbeisine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human mucoepidermoid carcinoma cells NCI-H292</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine; Ebeiedine; Suchengbeisine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine, ebeiedine, or suchengbeisine was superior to control in decreasing the expression of MUC5AC mucin gene.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zhou et al., 2017 [<xref rid="B73-ijms-20-01667" ref-type="bibr">73</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Puqiedine; Zhebeiresinol, 2-monopalmitin, N-demethylpuqietinone; Isoverticine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human embryonic kidney cells HEK293</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTB 10, 3, 1 mg/mL respectively; Dexamethasone 10<sup>&#x02212;5</sup> mol/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Puqiedine, zhebeiresinol, 2-monopalmitin, n-demethylpuqietinone or isoverticine was superior to control in reducing the expression of NF-&#x0039a;b level in cells.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xia et al., 2011 [<xref rid="B87-ijms-20-01667" ref-type="bibr">87</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 mice (CP/CPPS model)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control and blank normal: NS; FTB 0.1 mL/10 g, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract of FTB was superior to control in relieving the inflammation and over proliferation of fibroblasts of the prostate and reducing the serum level of nitric oxide in mice.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zhang et al., 1998 [<xref rid="B93-ijms-20-01667" ref-type="bibr">93</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 ICR mice (xylene induced ear swelling)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control: Purified water, ig,qd; Ethenzamide 0.3 g/kg, ig,qd; FTB 0.8, 2.4 g/kg respectively, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract of FTB was superior to control in releving the swelling of ear.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 ICR mice (carrageenin induced foot plantar swelling)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control: Purified water, ig,qd; Ethenzamide 0.3 g/kg, ig,qd; FTB 0.8, 2.4 g/kg respectively, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract of FTB was superior to control in releving the swelling of foot plantar.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xu et al., 2016 [<xref rid="B88-ijms-20-01667" ref-type="bibr">88</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human Embryonic Kidney Cells HEK293</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine concentrations 1, 3 10, 30, 100, 300 &#x003bc;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300 s</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine could inhibit the Nav 1.3 channel.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>6. Pain suppression</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zhang et al., 1998 [<xref rid="B92-ijms-20-01667" ref-type="bibr">92</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44 ICR mice (acetic acid induced pain)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control: Purified water, ig,qd; Ethenzamide 0.3 g/kg, ig,qd; FTB 0.8, 2.4 g/kg respectively, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract of FTB was superior to control in reducing the frequency of mouse writhing.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 ICR mice (thermal stimulus pain)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control: Purified water, ig,qd; Ethenzamide 0.3 g/kg, ig,qd; FTB 0.8, 2.4 g/kg respectively, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract of FTB was superior to control in increasing the remission period of tail-flick latency.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xu et al., 2016 [<xref rid="B88-ijms-20-01667" ref-type="bibr">88</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human Embryonic Kidney Cells HEK293</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine concentrations 1, 3 10, 30, 100, 300 &#x003bc;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300 s</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine could inhibit the Nav 1.7 channel.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>7. Antioxidation</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ruan et al., 2016 [<xref rid="B85-ijms-20-01667" ref-type="bibr">85</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total alkaloids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH radical; ABTS radical; FRAP reagent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH: Total alkaloids 50 &#x003bc;L; ABTS: Total alkaloids 50 &#x003bc;L; FRAP: Total alkaloids 20 &#x003bc;L, control ethanol 20 &#x003bc;L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH: 30 min; ABTS: Immediate; FRAP: Immediate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total alkaloids in FTB have strong a antioxidative capacity evidence by the results of DPPH, ABTS and FRAP.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ma, 2014 [<xref rid="B84-ijms-20-01667" ref-type="bibr">84</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">polysaccharide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DPPH radical</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">polysaccharide 0.1, 0.2, 0.4, 0.6, 0.8, 1 mg/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 min</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polysaccharide in FTB has strong antioxidative capacity evidence by the results of DPPH and absorption spectroscopy test.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>8. Antiulcer</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zhang et al., 2018 [<xref rid="B92-ijms-20-01667" ref-type="bibr">92</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90 SD rats (oral ulcer model)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank model: NS; FTB 4, 2, 1 g/kg respectively, external, qid; Gui Lin Xi Gua Shuang, 1 g/kg, external, qid </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract of FTB was superior to control in inhibiting oral ulcer.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">120 ICR mice (gastric ulcer model)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control: Purified water, ig,qd; Mepirizole 0.05 g/kg, ig,qd; FTB 0.8, 2.4 g/kg respectively, ig, qd; </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract of FTB was superior to control in inhibiting gastric ulcer.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>9. Anti-muscarinic</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zhou et al., 2006 [<xref rid="B75-ijms-20-01667" ref-type="bibr">75</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine; Peiminine; Puqietinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human Embryonic Kidney Cells HEK293</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Five alkaloids: 10&#x003bc;M (final concentration each); Negative control: carbachol, 0.3 &#x003bc;M (final concentration each); Positive control: Atropine 1 &#x003bc;M (final concentration each)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimine, peiminine or puqietinone was superior to control in raising the cAMP level in cells transfected with muscarinic M<sub>2</sub> receptor.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>10. Anti-thyroid</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lin et al., 2010 [<xref rid="B82-ijms-20-01667" ref-type="bibr">82</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">180 SD rats; 60 SPF mice (hyperthyroidism model)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control and blank model: NS, ig, qd; Tapazole 0.02 g/kg, ig, qd; FTB 3, 1.5, 0.75 g/kg respectively, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 days</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FTB was superior to control in reducing the serum level of T<sub>3</sub>, T<sub>4</sub>, cAMP, cGMP and raising the abilities of hypoxia tolerance.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>11. Regulation of blood rheology</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jiang et al., 2002 [<xref rid="B78-ijms-20-01667" ref-type="bibr">78</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 SD rats</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control: Purified water, ig,qd; FTB 1 mL respectively, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 week</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract of FTB was superior to control in reducing the whole blood viscosity, restricting the trythrocyte aggregation and raising the erythrocyte deformability.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>12. Anti-diarrhea</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zhang et al., 1998 [<xref rid="B93-ijms-20-01667" ref-type="bibr">93</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 ICR mice (castor oil induced diarrhea); 40 ICR mice (FXY induced diarrhea)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blank control: Purified water, ig,qd; Ethenzamide 0.3 g/kg, ig,qd; FTB 0.8, 2.4 g/kg respectively, ig, qd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alcohol extract of FTB was superior to control in reducing the frequency of diarrhea.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>13. Neuroprotection</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suh et al., 2018 [<xref rid="B8-ijms-20-01667" ref-type="bibr">8</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Frithunbol B; Ebeiedinone; 3&#x003b2;-hydroxy-5&#x003b1;-jervanin-12-en-6-one; Suchengbeisine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">lipopolysaccharide-activated BV-2 cells; C6 glioma cells </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO study: 100 ng/mL isolates; NGF study: 20 &#x003bc;M isolates</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 h</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Frithunbol B, ebeiedinone, and suchengbeisine significantly reduce the nitric oxide level, compared to control; 3&#x003b2;-hydroxy-5&#x003b1;-jervanin-12-en-6 -one was superior to control in increasing the nerve growth factor level.</td></tr></tbody></table><table-wrap-foot><fn><p>Note: ABTS: 2,2&#x02032;-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid); AZTB: An zi bei mu, Fritillaria unibracteata Hsiao et K. C. Hsia; CBM: Chuan bei mu, Fritillariae Cirrhosae Bulbus; CMC-Na: Sodium carboxyl methyl cellulose; CP/CPPS: Chronic prostatitis/chronic pelvic pain syndrome; DDP: Cisplatin; DPPH: 2,2-diphenyl-1-picrylhydrazyl; FRAP: Ferric reducing capacity; FTB: Fritillariae Thunbergii Bulbus, Zhe bei mu; FXY: Fan xie ye, Sennae Folium; FZ: Fu zi, Aconiti Radix Lateralis Praeparata; ICR: Institute of Cancer Research; NF-&#x003ba;B: Nuclear factor-&#x003ba;B; NGF: Nerve growth factor; NO: Nitric oxide; NS: Normal saline; P-gp: P-glycoprotein; SD: Sprague Dawley; SPF: Specific-pathogen-free; WBM: Wan bei mu, Fritillaria anhuiensis S.C.Chen et S.P.Yin; WBBM: Wa bu bei mu, Fritillaria unibracteata Hsiaoet K. C. Hsia var. wabuensis (S. Y. Tang et S. C. Yue) Z. D. Liu, S. Wang et S.C. Chen.</p></fn></table-wrap-foot></table-wrap><table-wrap id="ijms-20-01667-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-20-01667-t003_Table 3</object-id><label>Table 3</label><caption><p>Pharmacokinetics of peimine (A1) and peiminine (A2) and peimisine (A9) in Fritillariae Thunbergii Bulbus.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Included Studies</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Methods</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Animals</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Interventions</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">T<sub>1/2</sub> (h)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">T<sub>max</sub> (h)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CL/F (L/h/kg)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">V/F (L/kg)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">C<sub>max</sub> (&#x003bc;g/L)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AUC<sub>0-t</sub> (&#x003bc;g h/L)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AUC<sub>0-</sub><sub>&#x0221e;</sub> (&#x003bc;g h/L)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chen et al., 2011 [<xref rid="B76-ijms-20-01667" ref-type="bibr">76</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-MS-MS; DAS 2.0 package</td><td align="center" valign="middle" rowspan="1" colspan="1">12 female SD rats</td><td align="center" valign="middle" rowspan="1" colspan="1">Peimine, 4.25 g/kg, ig</td><td align="center" valign="middle" rowspan="1" colspan="1">4.8 &#x000b1; 0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">1.5 &#x000b1; 0.6</td><td align="center" valign="middle" rowspan="1" colspan="1">119.6 &#x000b1; 40.1</td><td align="center" valign="middle" rowspan="1" colspan="1">854.8 &#x000b1; 363.9</td><td align="center" valign="middle" rowspan="1" colspan="1">43.2 &#x000b1; 5.4</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">260.5 &#x000b1; 119.8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Peiminine, 4.25 g/kg, ig</td><td align="center" valign="middle" rowspan="1" colspan="1">6.6 &#x000b1; 3.2</td><td align="center" valign="middle" rowspan="1" colspan="1">4.5 &#x000b1; 1.9</td><td align="center" valign="middle" rowspan="1" colspan="1">34.1 &#x000b1; 4.8</td><td align="center" valign="middle" rowspan="1" colspan="1">321.1 &#x000b1; 155.4</td><td align="center" valign="middle" rowspan="1" colspan="1">57.6 &#x000b1; 23.0</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">618.3 &#x000b1; 94.8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chen et al., 2013 [<xref rid="B77-ijms-20-01667" ref-type="bibr">77</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-MS-MS; DAS 2.0 package</td><td align="center" valign="middle" rowspan="1" colspan="1">6 female SD rats</td><td align="center" valign="middle" rowspan="1" colspan="1">Peimine, 4.25 g/kg, ig</td><td align="center" valign="middle" rowspan="1" colspan="1">4.2 &#x000b1; 2.0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.5 &#x000b1; 0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">128.9 &#x000b1; 32.6</td><td align="center" valign="middle" rowspan="1" colspan="1">781.3 &#x000b1; 305.6</td><td align="center" valign="middle" rowspan="1" colspan="1">43.7 &#x000b1; 22.7</td><td align="center" valign="middle" rowspan="1" colspan="1">214.2 &#x000b1; 84.6</td><td align="center" valign="middle" rowspan="1" colspan="1">214.3 &#x000b1; 84.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Peiminine, 4.25 g/kg, ig</td><td align="center" valign="middle" rowspan="1" colspan="1">3.4 &#x000b1; 1.7</td><td align="center" valign="middle" rowspan="1" colspan="1">2.8 &#x000b1; 0.9</td><td align="center" valign="middle" rowspan="1" colspan="1">36.3 &#x000b1; 15.8</td><td align="center" valign="middle" rowspan="1" colspan="1">268.8 &#x000b1; 163.9</td><td align="center" valign="middle" rowspan="1" colspan="1">64.2 &#x000b1; 40.0</td><td align="center" valign="middle" rowspan="1" colspan="1">571.0 &#x000b1; 243.4</td><td align="center" valign="middle" rowspan="1" colspan="1">571.1 &#x000b1; 243.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">6 SD male rats</td><td align="center" valign="middle" rowspan="1" colspan="1">Peimine, 4.25 g/kg, ig</td><td align="center" valign="middle" rowspan="1" colspan="1">6.2 &#x000b1; 1.9</td><td align="center" valign="middle" rowspan="1" colspan="1">2.9 &#x000b1; 1.7</td><td align="center" valign="middle" rowspan="1" colspan="1">41.5 &#x000b1; 20.1</td><td align="center" valign="middle" rowspan="1" colspan="1">374.1 &#x000b1; 186.2</td><td align="center" valign="middle" rowspan="1" colspan="1">57.6 &#x000b1; 21.6</td><td align="center" valign="middle" rowspan="1" colspan="1">662.4 &#x000b1; 277.9</td><td align="center" valign="middle" rowspan="1" colspan="1">665.3 &#x000b1; 213.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Peiminine, 4.25 g/kg, ig</td><td align="center" valign="middle" rowspan="1" colspan="1">5.1 &#x000b1; 1.4</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0 &#x000b1; 1.4</td><td align="center" valign="middle" rowspan="1" colspan="1">10.5 &#x000b1; 2.6</td><td align="center" valign="middle" rowspan="1" colspan="1">92.2 &#x000b1; 55.1</td><td align="center" valign="middle" rowspan="1" colspan="1">135.6 &#x000b1; 40.2</td><td align="center" valign="middle" rowspan="1" colspan="1">1965.5 &#x000b1; 433.3</td><td align="center" valign="middle" rowspan="1" colspan="1">1969.6 &#x000b1; 433.5</td></tr><tr><td rowspan="3" align="center" valign="middle" colspan="1">Tong, 2016 [<xref rid="B49-ijms-20-01667" ref-type="bibr">49</xref>]</td><td rowspan="3" align="center" valign="middle" colspan="1">In vivo</td><td rowspan="3" align="center" valign="middle" colspan="1">UHPLC-MS/MS; DAS 2.0 package</td><td rowspan="3" align="center" valign="middle" colspan="1">6 SD male rats; 6 female SD rats</td><td align="center" valign="middle" rowspan="1" colspan="1">Peimine, 0.45 g/kg, ig</td><td align="center" valign="middle" rowspan="1" colspan="1">2.7 &#x000b1; 0.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5 &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">40.8 &#x000b1; 17.6</td><td align="center" valign="middle" rowspan="1" colspan="1">3.7 &#x000b1; 0.9</td><td align="center" valign="middle" rowspan="1" colspan="1">10.5 &#x000b1; 1.7</td><td align="center" valign="middle" rowspan="1" colspan="1">10.6 &#x000b1; 1.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Peiminine, 0.45 g/kg, ig</td><td align="center" valign="middle" rowspan="1" colspan="1">1.9 &#x000b1; 0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7 &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">9.6 &#x000b1; 5.0</td><td align="center" valign="middle" rowspan="1" colspan="1">12.6 &#x000b1; 2.0</td><td align="center" valign="middle" rowspan="1" colspan="1">37.1 &#x000b1; 13.7</td><td align="center" valign="middle" rowspan="1" colspan="1">37.1 &#x000b1; 13.8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Peimisine, 0.45 g/kg, ig</td><td align="center" valign="middle" rowspan="1" colspan="1">4.0 &#x000b1; 1.0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8 &#x000b1; 0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">12.1 &#x000b1; 4. 9</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2 &#x000b1; 0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">4.6 &#x000b1; 2.0</td><td align="center" valign="middle" rowspan="1" colspan="1">4.7 &#x000b1; 2.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Xu et al., 2017 [<xref rid="B59-ijms-20-01667" ref-type="bibr">59</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" rowspan="1" colspan="1">UHPLC-MS/MS; DAS 2.0 package</td><td align="center" valign="middle" rowspan="1" colspan="1">6 male SD rats</td><td align="center" valign="middle" rowspan="1" colspan="1">Peimine, 20 g/kg, ig</td><td align="center" valign="middle" rowspan="1" colspan="1">2.3 &#x000b1;0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">2.8 &#x000b1; 1.4</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">74.7 &#x000b1; 18.2</td><td align="center" valign="middle" rowspan="1" colspan="1">474.5 &#x000b1; 143.4</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peimisine, 20 g/kg, ig</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.68 &#x000b1; 0.78</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.3 &#x000b1; 1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.1 &#x000b1; 2.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">120.7 &#x000b1; 31.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr></tbody></table><table-wrap-foot><fn><p>Note: DAS 2.0: Drug and Statistic 2.0; N/A: Not applicable; SD: Sprague Dawley. </p></fn></table-wrap-foot></table-wrap></floats-group></article>